Adult Medicine Ambulatory Care Cardiology Central Nervous System Clinical Administration Critical Care Drug Information

Education and Training Emergency Medicine Endocrine and Metabolism Geriatrics GI/Liver/Nutrition Health Outcomes Hematology/Oncology Immunology/Transplantation

Infectious Diseases Nephrology Pain and Palliative Care Pediatrics Pharmaceutical Industry PK/PD/PG Women’s Health

Introduction:

The Adult Medicine PRN consists of practitioners, residents, and students who share interest in shaping the practice of adult medicine in a variety of settings through research and practice. The following paragraphs highlight some of the Adult Medicine PRN’s activities and member accomplishments.

For the ACCP Annual Meeting, the Adult Medicine PRN Programming Committee has been actively planning a focus session highlighting the optimal use of dual antiplatelet therapy. Practitioners will have the opportunity to review current evidence regarding indications for antiplatelet therapy and strategies for preventing complications from treatment.

The PRN Archives Committee has been busy developing and revising online content and ensuring the content and format are best suited for our members. Our Training and Travel Awards Committee has received applications and will be awarding students and new practitioners with travel awards during the ACCP Annual Meeting. The Nominations Committee has also reviewed applications and will be presenting awards at the upcoming Annual Meeting.

Promotions:

• Joel C. Marrs, Pharm.D., FNLA, BCPS (AQ Cardiology), BCACP, CLS, has been promoted to associate professor at the University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences.
• Grant E. Sklar, Pharm.D., BCPS, has been promoted to senior principal clinical pharmacist, Department of Pharmacy, National University Hospital, Singapore.

Publications:

• See S, Conry J. Flip my class! A faculty development demonstration of a flipped classroom. Curr Pharm Teach Learn 2014;6:585-8.
• Hagstrom K, Nailor M, Lindberg M, Hobbs L, Sobieraj DM. Association of potentially inappropriate medication use in the elderly and hospital-related outcomes. J Am Geriatr Soc 2014. In press.
• Kang N, Sobieraj DM. Indirect treatment comparison of new oral anticoagulants for the treatment of venous thromboembolism. Thromb Res 2014;133:1145-51.
• Kohn CG, Coleman CI, White CM, Sidovar MF, Sobieraj DM. Mobility, walking and physical activity in persons with multiple sclerosis. Curr Med Res Opin 2014. [Epub ahead of print]
• Phung OJ, Sobieraj DM, Engel SS, Rajpathak SN. Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis. Diabetes Obes Metab 2014;16:410-7.

Other Notable Achievements:

• Kelly Holcomb, Pharm.D., was invited to present an oral presentation titled “Survey of Antibiotic Utilization for Treatment of Mycobacterium abscessus Infection Amongst Cystic Fibrosis Accredited Care Centers” at the 2014 North American CF Conference held in October in Atlanta, Georgia.
• Beth H. Resman-Targoff, Pharm.D., FCCP, gave a talk on March 28 titled “Individualizing Rheumatoid Arthritis Therapy.” American Pharmacists Association Annual Meeting and Exposition, Orlando, FL. This was one of 11 sessions selected by APhA for videotaping for use as a home-study offering.
• Diane Rhee, Pharm.D., was invited to give a presentation titled “Inhaled Antibiotics in the Non-cystic Fibrosis Adult Population – How Should We Use Them?” Presented at: 2014 California Society of Health-System Pharmacists Seminar Meeting; October 2014; San Francisco, CA.
• Elizabeth Sebranek-Evans, Pharm.D., was invited to give two presentations: “’Lytes Done Right: Safe Use of Fluids and Electrolytes” and “PK, PD, and FAQ: Effects of Bariatric Surgery on Nutrient and Drug Disposition.” Presented at: 2014 California Society of Health-System Pharmacists Seminar Meeting; October 2014; San Francisco, CA.
• Sharon See, Pharm.D., FCCP, BCPS, was named the 2015 chair of the BPS Specialty Council on Pharmacotherapy.

Introduction:

This has been a year of “Building Better” for the Ambulatory Care PRN. Membership has risen from about 1700 members in October 2013 to a projected 2000 members by October 2014! This year, the PRN funded three Focused Investigator Training Scholarships and six members’ ACCP Academy applications for the Annual Meeting. The PRN has developed informational flyers promoting membership/involvement in the PRN for local ACCP student chapters and second-year residencies in ambulatory care, as well as piloted the implementation of the first PRN Facebook page. In addition, a virtual symposium for research presentations was held. The PRN has continued to advocate for provider status and has worked through its Advocacy Committee to keep the membership updated on the changing political landscape in relation to ACCP’s provider status initiative. All of our members have been hard at work this year, and we are honored that they have chosen to be part of the Ambulatory Care PRN. Please see the information that follows for a list of submitted achievements.

Promotions:

• Brian K. Irons, Pharm.D., FCCP, BCACP, BCPS, BC-ADM: Professor, School of Pharmacy, Texas Tech University Health Sciences Center
• Mary Ann Kliethermes, Pharm.D., B.S.: Professor, Chicago College of Pharmacy, Midwestern University, Downers Grove, Illinois
• Joel C. Marrs, Pharm.D., FNLA, BCPS (AQ Cardiology), BCACP, CLS: Associate professor, University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences
• Katie S. McClendon, Pharm.D., BCPS: Clinical associate professor and appointed assistant dean for student services at Jackson Campus and director of student affairs for the Department of Pharmacy Practice, all with the University of Mississippi School of Pharmacy
• Lauren Peyton, Pharm.D., CDE: Associate professor of pharmacy practice, Union University School of Pharmacy
• Michelle Rager, Pharm.D., BCPS, CDE: Associate professor of pharmacy practice, Shenandoah University
• Andrew J. Smith, Pharm.D., BCPS (AQ Cardiology): Clinical associate professor, UMKC School of Pharmacy
• Mikayla L. Spangler, Pharm.D., BCPS: Associate professor, Creighton University School of Pharmacy and Health Professions
• Brad M. Wright, Pharm.D., BCPS: Associate professor, Auburn University Harrison School of Pharmacy

Awards:

• Justin Bouw, Faculty Service Award and Faculty of the Year for the Class of 2014
• Andrew Bzowyckyj, 2014 AADE Pharmacy Best Practices in Diabetes Care Award
• Kelly Cochran, Missouri Pharmacy Association Faculty Member of the Year
• Mary Beth O’Connell, Excellence in Teaching Award; Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University
• Angela N. Skaff, ASHP Student Leadership Award, Cardinal Health Scholarship, and FSHP Paul Magalian Student Leadership Award
• Robert Talbert, Robert K. Chalmers Award for Distinguished Teaching from AACP

Grants:

• Sarah L. Anderson, Pharm.D., BCPS: Million Hearts® Educational Outreach Grant, $4000
• Sarah L. Anderson, Pharm.D., BCPS: University of Colorado Skaggs School of Pharmacy Department of Clinical Pharmacy Seed Grant, $13,792
• Karen Gunning, Pharm.D., FCCP, BCPS: “Pharmacist to Treat” grant from the Utah Department of Health through the CDC Million Hearts Initiative, $25,000
• Karen R. Sando, Pharm.D., BCACP, CDE: “Improving Geriatric Care Through Pharmacist-Physician Collaboration with the Medicare Annual Wellness Visit.” W. Martin Smith Interdisciplinary Patient Safety and Quality Award, $18,840
• Maria Miller Thurston, Pharm.D., BCPS: Moye P, Lovett AW, Thurston MM, Liao TV, Advani A, Huang V. “Utilization of a Multidisciplinary Team to Reduce the Rate of Hospital Readmissions in Heart Failure Patients at a Community Teaching Hospital: The Pharmacist’s Role.” 2013 ASHP Foundation PPMI Demonstration Grant Program, $22,788

Publications:

• Sarah L. Anderson, Pharm.D., BCPS
  • Anderson SL, Vande Griend JP. Quetiapine for insomnia: a review of the literature. Am J Health Syst Pharm 2014;71:394-402.
  • King WM IV, Saseen JJ, Anderson SL. Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. First published online on April 3, 2014, at doi: 10.1177/2040622314530460.
  • Woodward HN, Anderson SL. Once-weekly albiglutide in the management of type 2 diabetes: patient considerations. Patient Prefer Adherence 2014;8:789-803.
  • Anderson SL. Establishing clinical pharmacy services in cardiology. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program. Cardiology Care. Lenexa, KS: American College of Clinical Pharmacy, 2014:245-67.
  • Anderson SL. Dapagliflozin efficacy and safety: a perspective review. Ther Adv Drug Saf 2014. In press.
• Emily M. Armstrong, Pharm.D., BCACP; Jessica Bellone, Pharm.D., BCACP; Lori Hornsby, Pharm.D., BCPS; and Haley Phillippe, Pharm.D., BCPS
  • Armstrong EM, Bellone J, Hornsby LB, Treadway S, Phillippe HM. Acquired thrombophilia. J Pharm Pract 2014;27:234-42.
  • Armstrong EM, Bellone J, Hornsby LB, Treadway S, Phillippe HM. Pregnancy-related venous thromboembolism. J Pharm Pract 2014;27:243-52.
  • Phillippe HM, Hornsby LB, Treadway S, Armstrong EM, Bellone J. Inherited thrombophilia. J Pharm Pract 2014;27:227-33.
  • Hornsby LB, Armstrong EM, Bellone J, Treadway S, Phillippe HM. Thrombophilia screening. J Pharm Pract 2014;27:253-9.
• Kassandra Bartelme, Pharm.D., BCACP
  • Bartelme K, Bzowyckyj A, Frueh J, Speedie M, Jacobson G, Sorensen TD. Experience and outcomes of a pharmaceutical care leadership residency program. Innov Pharm 2014;5:Article TBA. Available at www.pharmacy.umn.edu/innovations/prod/groups/cop/@pub/@cop/@innov/documents/article/cop_article_486296.pdf.
• Melissa G. Butler, Pharm.D., MPH, BCPSH
  • Schmittdiel JA, Raebel MA, Dyer W, Xu S, Goodrich GK, Schroeder EB, Segal JB, O’Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Karter AJ, Lafata JE, Butler MG, Steiner JF. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014;54:374-82.
  • Raebel MA, Ellis JL, Schroeder EB, Xu S, O’Connor PJ, Segal JB, Butler MG, Schmittdiel JA, Kirchner HL, Goodrich GK, Lawrence JM, Steiner JF. Intensification of antihyperglycemic therapy among patients with incident diabetes: a SUrveillance PREvention and ManagEment of Diabetes Mellitus (SUPREME-DM) study. Pharmacoepidemiol Drug Saf 2014;23:699-710.
  • Schmittdiel JA, Dyer W, Uratsu C, Magid D, O’Conner PJ, Beck A, Butler MG, Ho M, Vasquez-Benitz G, Adams AS. Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression. J Clin Hypertens (Greenwich) 2014;16:412-7.
  • Xu S, Schroeder EB, Shetterly S, Goodrich GK, O’Connor PJ, Steiner JF, Schmittdiel JA, Desai J, Pathak RD, Neugebauer R, Butler MG, Kirchner L, Raebel MA. Accuracy of hemoglobin A1c imputation using fasting plasma glucose in diabetes research using electronic health records data. SOIC 2014;2:93-104.
  • Murphy MV, Du D, Hua W, Butler MG, Davis RL, Johnson L, Nakasato C, Nordin JD, Ramesh M, Schum M, von Worley A, Zinderman C, Platt R, Klompas M. The utility of claims data for anterior cruciate ligament infection surveillance. Infect Control Hosp Epidemiol 2014;35:652-9.
  • Li L, Vollmer WM, Butler MG, Wu P, Kharbanda EO, Wu AC. A comparison of confounding adjustment methods for asthma controller medication effectiveness assessment. Am J Epidemiol 2014;179:648-59.
• Lisa M. Chastain, Pharm.D., BCPS, BCACP
  • Chastain LM, Stapleton M, Frost J. A comparison of US treatment guidelines for type 2 diabetes mellitus: applications to the newly diagnosed patient. Diabetes Manage 2014;4:273-83.
• Marie Davies, Pharm.D.
  • Davies ML, Johnson MD, Brown JN, Bryan WE, Townsend ML. Predictors of glycemic control among HIV-positive veterans with diabetes. Int J STD AIDS 2014 May 14. [Epub ahead of print]
• Elisa M. Greene, Pharm.D., BCACP
  • Greene E, Oman K, Lefler M. Possible Energy Drink-Induced Acute Kidney Injury. Ann Pharmacother 2014 Jul 1. [Epub ahead of print]
  • Shelquist R, Greene E. On house calls, healthcare, and hope: one student’s perspective. Innovations 2014;5:142-3.
• Jennifer Goldman-Levine, Pharm.D., FCCP, BC-ADM, CDE
  • Sparkes S, Patel D, Goldman-Levine JD. Past, present and future research avenues for metformin: a literature review. J Pharm Technol. Published online before print; July 2014. Available at http://pmt.sagepub.com/content/early/2014/07/24/8755122514544527.abstract.
  • Dvorkin Camiel L, Goldman-Levine JD, Kostka-Rokosz M, McCloskey W, Tataronis G. Use of Twitter to create a personal learning network in a required pharmacy course. Curr Pharm Teach Learn 2014;6:463-70. Published online April 14, 2014. Available at www.pharmacyteaching.com/article/S1877-1297%2814%2900052-5/abstract.
  • Dvorkin Camiel L, Goldman-Levine JD, Kostka-Rokosz M, McCloskey W. Twitter as an in-class backchannel tool in a large required pharmacy course. Am J Pharm Educ 2014;78:Article 67.
  • Goldman-Levine JD. Insulin patch pumps: a new tool for type 2. Diabetes Self Manage 2014;31:10, 12, 14.
• Melody L. Hartzler, Pharm.D., CAE; and Elizabeth W. Young, Pharm.D., BCPS
  • Denetclaw TH, Young EW, Tiemeier AM, Scott JD, Hartzler ML. Perceptions, obstacles, and solutions for offering introductory pharmacy practice experiences in the community hospital setting: a qualitative survey. Curr Pharm Teach Learn 2014;6:632-8. Available at http://dx.doi.org/10.1016/j.cptl.2014.05.
• Robert Hutchison, Pharm.D.
  • Hutchison R. Treating diabetes in underserved populations using an interprofessional care team. J Interprof Care 2014.
• Eric Ip, Pharm.D., FCSHP, BCPS, CSCS, CDE
  • Yoshizuka K, Perry PJ, Upton G, Lopes I, Ip EJ. Standardized field sobriety test: false-positive test rate among sober subjects. J Forensic Toxicol Pharmacol 2014;3:2.
  • Truong JT, Barnett MJ, Tang TT, Ip EJ, Teeters JL, Knapp KK. Factors impacting self-perceived readiness for residency training: results of a national survey of postgraduate year one residents. J Pharm Pract 2014 Mar 27. [Epub ahead of print]
  • Ip EJ, Trinh K, Tenerowicz MJ, Pal J, Lindfelt TA, Perry PJ. Characteristics and behaviors of older male anabolic steroid users. J Pharm Pract 2014 Mar 18.
  • Ip EJ, Pal J, Yu J, Trinh K, Lopes I, Lindfelt T, Perry PJ. Effects of dextromethorphan on the standardized field sobriety test. Calif J Health Syst Pharm 2014;26:52-7.
• Matt Kostoff, Pharm.D., BCPS
  • Kostoff MD, Saseen JJ, Borgelt LM. Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy. Int J Womens Health 2014;6:423-8.
  • Whitney Maxwell, Pharm.D., BCPS
  • Ramsey LB, Johnson SG, Caudle KE, Haidar CE, Voora D, Wilke RA, Maxwell WD, et al. The Clinical Pharmacogenomics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. Clin Pharmacol Ther 2014 Jun 11. [Epub ahead of print]
  • Lu ZK, Kessler SJ, Schulz R, Bian J, Chen B, Wu J, Noxon V, Rao G, Leibnitz R, Restaino J, Maxwell WD, et al. Systematic approach to pharmacovigilance beyond the limits: the Southern Network on Adverse Reactions (SONAR) projects. Adv Pharmacoepidemiol Drug Saf 2014;3:149-61.
  • Maxwell WD, Jacob MW, Spiryda LB, Bennett CL. Selection of contraceptive therapy for patients with thrombophilia: a review of the evidence. J Womens Health 2014;23:318-26.
• Katie S. McClendon, Pharm.D., BCPS
  • Wright EA, Brown B, Gettig J, Martello JL, McClendon KS, Smith KM, Teeter J, Ulbrich TR, Wegrzyn N, Bradley-Baker LR. Teaching and learning curriculum programs: recommendations for postgraduate pharmacy experiences in education. Am J Health Syst Pharm 2014;71:1292-302.
  • Rafie S, McIntosh J, Shealy KM, Borgelt LM, Forinash A, Shrader SP, Koepf ER, McClendon KS, Griffin BL, Horlen C, Karaoui LR, Rowe EL, Lodise NM, Wigle PR. Pharmacist roles in long-acting reversible contraception use: an opinion of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2014 Jul 3. [Epub ahead of print]
  • McClendon KS, Malinowski SS, Pitcock JJ, Brown MA, Davis CS, Sherman JJ, Riche DM, Bloodworth LS, Warrington LE. A multipreceptor approach to ambulatory care topic discussions. Am J Pharm Educ 2014;78:77.
  • McClendon KS, Stover KR. Tips for a successful poster presentation. Am J Health Syst Pharm 2014;71:449-51.
• Mary Beth O’Connell, Pharm.D.
  • Engle JP, Erstad B, Anderson DC Jr, Bucklin MH, Chan A, Donaldson AR, Hagemann TM, O’Connell MB, Rodgers PT, Schwinghammer T, Tennant S, Thomas Z. Minimum qualifications for clinical pharmacy practice. Pharmacotherapy 2014;34:534.
  • O’Connell MB, Borchert J. Osteoporosis and other metabolic bone disorders in pharmacotherapy, 8th ed. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. 2014:1477-504.
• Jessica O’Neill, Pharm.D., BCACP, CLS
• O’Neill JL, Cunningham TL, Wiitala WL, Bartley EP. Collaborative hypertension case management by registered nurses and clinical pharmacy specialists within the Patient Aligned Care Teams (PACT) model. J Gen Intern Med 2014;29(suppl 2):S675-81.
• Sweta M. Patel, Pharm.D., BCPS
  • Patel S, Thompson AN. Screening, diagnosis, and management of type II diabetes: a review of the 2014 American Diabetes Association guidelines. Ment Health Clin 2014;4:75.
  • Patel S, Nappi J, Thompson AN. Effectiveness of pharmacy-run anticoagulation clinics compared to large clinical trials of new oral anticoagulants. J Pharma Care Health Syst 2014;1:101.
• Lauren Peyton, Pharm.D., CDE
  • Lauren Peyton and Joy Greene. Irritable bowel syndrome: current and emerging treatment options. P T. To be published August 2014.
• Sharon See, Pharm.D., FCCP, BCPS
  • See S, Conry J. Flip my class! A faculty development demonstration of a flipped classroom. Curr Pharm Teach Learn 2014;6:585-8.
• Robert L. Talbert, Pharm.D., FCCP, FAHA, BCPS
  • Hart RG, Pearce LA, Bakheet MF, Benavente OR, Conwit RA, McClure LA, Talbert RL, Anderson DC. Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial. J Stroke Cerebrovasc Dis 2013.
  • Cote R, Hart R, McClure L, Anderson D, Talbert RL, Benavente O. ASA failure: does the combination of ASA and clopidogrel confer better long-term vascular protection? Neurology 2014.
  • Pergola PE, White CL, Szychowski JM, Grimm R, Talbert RL, Benavente O, et al. Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study. Am J Hypertens 2014 Mar 7.
  • Gray H, Seltzer J, Talbert RL. The risk for recurrent prostate cancer in prostate cancer survivors receiving testosterone supplementation for hypogonadism. Am J Health Syst Pharm. Accepted for publication.

New ACCP Fellows:

• Samantha Karr, Pharm.D., BCPS, BCACP, BC-ADM; Midwestern University
• Joel C. Marrs, Pharm.D., FNLA, BCPS (AQ Cardiology), BCACP, CLS; Skaggs School of Pharmacy & Pharmaceutical Sciences
• M. Shawn McFarland, Pharm.D., BCPS, BCACP, BC-ADM; VA Tennessee Valley Healthcare System, Alvin C. York Campus and University of Tennessee College of Pharmacy
• Julie M. Sease, Pharm.D., BCPS, BCACP, CDE; Presbyterian College School of Pharmacy
• Mitzi Wasik, Pharm.D., BCPS; Aetna

Other Notable Achievements:

• Lyndsey N. Hogg, Pharm.D., BCACP: Selected by the Kansas Board of Pharmacy to serve on the newly established Collaborative Drug Therapy Management Advisory Board for the State of Kansas
• Eric J. Ip, Pharm.D., FCSHP, BCPS, CSCS, CDE: Named a 2014 fellow of the California Society of Health-System Pharmacists
• Samantha Karr, Pharm.D., BCPS, BCACP, BC-ADM: Elected vice chair for the Board of Pharmaceutical Specialties Specialty Council on Ambulatory Care Pharmacy for 2015
• Shannon Reidt, Pharm.D.: AFPE Faculty Development Fellowship in Geriatric Pharmacy
• Tiffany R. Shin, Pharm.D., BCACP: Selected by the Kansas Board of Pharmacy to serve on the newly established Collaborative Drug Therapy Management Advisory Board for the State of Kansas

Other:

• Marie Davies: Hired as assistant professor of pharmacy practice & administration at Western University of Health Sciences College of Pharmacy
• Eric Jackson: Retired after 30 years in the Department of Family Medicine

Introduction:

The ACCP Cardiology PRN completed planning for the 2014 Annual Meeting, circulated the annual PRN newsletter, and began the process of evaluating candidates for Cardiology PRN awards (e.g., seed grant awards, travel awards). Task force groups worked on increasing PRN collaboration and PRN-written publications. The Cardiology PRN also held the inaugural online Cardiology PRN Journal Club, with PGY2 cardiology residents as presenters.

Promotions:

• Sally Arif was promoted to an associate professor with tenure at Midwestern University Chicago College of Pharmacy (July 1, 2014).
• Mike Dorsch was promoted to a clinical associate professor at the University of Michigan College of Pharmacy.
• Lingyun Lu was appointed as an assistant professor at California Northstate University College of Pharmacy.
• Joel C. Marrs was promoted to an associate professor at the University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences.
• Robert Lee Page II was promoted to a professor at the University of Colorado, Skaggs School of Pharmacy.
• Mary Parker was promoted to a clinical pharmacist specialist and clinic coordinator - ambulatory care (8A) at Durham VA Medical Center.
• Andrew Smith, Pharm.D., BCPS (AQ Cardiology), was promoted to a clinical associate professor, UMKC School of Pharmacy.
• Jodi Taylor, Pharm.D., BCPS, was promoted to an associate professor of pharmacy practice, Union University School of Pharmacy.
• Jonathan Thigpen obtained an assistant professor faculty position at Notre Dame of Maryland University.

Awards:

• Sally Arif was awarded the PS-2 Teacher of the Year at Midwestern University Chicago College of Pharmacy (May 2014).
• Sheryl Chow was named the 2013–2015 vice chair, AHA Clinical Pharmacology Committee, Clinical Cardiology Council, Writing Group Chair, AHA Advisory Statement: “The Role of Biomarkers for the Prevention, Assessment, and Management of HF.”
• Dave Dixon received the AACP Innovations in Teaching Portfolio Award in July.
• Steven Dunn was named a fellow of AHA.
• Abir Kanaan and Jennifer Donovan received the 2014 Faculty Scholarship Award in the area of integration for the following publication: Kanaan AO, Donovan JL, Tjia J, Field TS, Gagne S, Garber L, Cutrona SL, Harrold LR, Preusse P, Reed G, Gurwitz JH. Identification of adverse drug events post-hospital discharge in a geriatric population. J Am Geriatr Soc 2013;61;1894-9.
• Lingyun Lu and Cynthia A. Jackevicius received CV Team Best Poster at the ACCP 2014 Scientific Session, Washington, DC, for the following abstract: Lu L, Jackevicius CA, De Leon N, Warner A, Chang D, Mody FV. Impact of a multi-disciplinary heart failure post-discharge management clinic on medication adherence.
• Jacqueline S. Marinac received the AstraZeneca AZSprire Award, the top national performance award for employees with 2 years’ or less experience.
• Carleton Maxwell was installed as the National President of the National Pharmaceutical Association 2014–2016 on July 21, 2014.
• Nikhat Syed received Added Qualifications in Cardiology.
• Nikhat Syed completed a master’s degree in business administration from North Carolina State University.

Grants:

• Sally Arif received the American Heart Association Community Innovation Grant ($4500) for a project titled “Cardiovascular and Diabetes Screening Program for the Middle-Eastern Community of Chicagoland” (June 2014).
• William Baker: Connecticut Institute for Clinical and Translational Sciences (CICATS) Career Development Award (Pre-K): $108,788 (July 1, 2014 – June 30, 2016)
• Sheryl L. Chow, principal investigator for title: I-PRESERVE biomarker study: ST2 on Treatment Effect and Outcomes in Patients with Preserved Ejection Fraction
• James Coons: Coinvestigator: Using Personal Genome Testing to Teach Pharmacogenomics in a Large Lecture Course. Innovation in Education Award. Provost’s Advisory Council on Instructional Excellence. May 1, 2014 – April 30, 2015. Grant total: $18,708
• Critical Diagnostics, $20,000 in-kind contribution
• Sony Tuteja-Stevens: Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation, Research Starter Grant in Translational Medicine and Therapeutics. “Metabolomics-Guided Pharmacogenomics of Niacin”

Publications:

• Anderson M, Hassell K, Trujillo T, Wolfe B. Perioperative management of the target-specific oral anticoagulants. Cleve Clin J Med. In press.
• Azim S, Baker WL, White WB. Evaluating cardiovascular safety of novel therapeutic agents for the treatment of type 2 diabetes mellitus. Curr Cardiol Rep 2014. In press.
• Babilonia K, Golightly L, Hassell K, Kaiser JN, Kiser TH, Klem P, Trujillo T. Antithrombotic therapy in thrombocytopenic cancer patients: efficacy and safety of reduced-dose low-molecular-weight heparin during hospitalization. Clin Appl Thromb Hemost 2014 Jul 14. [Epub ahead of print]. http://cat.sagepub.com/cgi/reprint/1076029614543140v1.pdf?ijkey=MKcMAwKXzykuNtZ&keytype=ref
• Babilonia K, Trujillo TC. The role of prothrombin complex concentrates in reversal of target specific anticoagulants. Thromb J 2014;12:8.
• Baker WL, Chamberlin KW. New oral anticoagulants versus warfarin treatment – no need for pharmacogenomics? Point-Counterpoint. Clin Pharmacol Ther 2014;96:17-9.
• Beavers CJ, Alburikan KA, Rodgers JE, Dunn SP, Reed BN. Distinguishing anemia and iron deficiency of heart failure: signal for severity of disease or unmet therapeutic need? Pharmacotherapy 2014;34:719-32.
• Coons JC, Miller T. Strategies to reduce bleeding risk in acute coronary syndromes and percutaneous coronary intervention: new and emerging pharmacotherapeutic considerations. Pharmacotherapy 2014. [Epub ahead of print]
• DiDomenico RJ, Na-Thalang K, Tsao YY, Bress AP, Groo VL, Deyo KL, Patel SR, Bishop JR, Bauman JL. Use of a simplified nomogram to individualize digoxin dosing in heart failure patients vs. standard care. Pharmacotherapy. In press.
• Dobesh PP. Economic implications of inadequate treatment of venous thromboembolism and potential solutions. J Pharm Pract 2014;27:178-86.
• Gurwitz JH, Field TS, Ogarek J, Tjia J, Cutrona SL, Harrold LR, Gagne SJ, Preusse P, Donovan JL, Kanaan AO, Reed G, Garber L. An electronic health record-based intervention to increase follow-up office visits and decrease rehospitalization in older adults. J Am Geriatr Soc 2014;62:865-71.
• Harris J, Coons JC. Ticagrelor use in a patient with a documented clopidogrel hypersensitivity. Ann Pharmacother 2014;48:1230-3.
• Hester EK, McBane SE, Bottorf MB, Carnes TA, Dell K, Gonyeau MJ, Greco AJ, McConnell KJ, Sanoski CA, Skaar DJ, Splinter MY, Trujillo TC. ACCP position statement: educational outcomes necessary to enter pharmacy residency training. Pharmacotherapy 2014;34:e22-e25.
• Kanaan A. Elastic compression stockings fail to prevent post-thrombotic syndrome after a first deep vein thrombosis. Evid Based Nurs 2014 Jun 17. doi: 10.1136/eb-2014-101873. This was an invitation. Commentary on Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomized placebo-controlled trial. Lancet 2014;383:880-8.
• Koehler JM, Tisdale JE. Hypertension. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook. A Patient-Focused Approach, 9th ed. New York: McGraw-Hill, 2014:57-60.
• Lanfear DE, Chow SL, Padhukasahasram B, Li J, Langholz D, Tang W, Williams K, Sabbah HN. Genetic and non-genetic factors influencing pharmacokinetics of B-type natriuretic peptide. J Card Fail. In press.
• Li L, Vollmer WM, Butler MG, Wu P, Kharbanda EO, Wu AC. A comparison of confounding adjustment methods for asthma controller medication effectiveness assessment. Am J Epidemiol 2014;179:648-59.
• Limone BL, Baker WL, Mearns ES, White CM, Kluger J, Coleman CI. Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation. J Clin Epidemiol 2014; published online July 10, 2014.
• Lind SE, Boyle ME, Fisher S, Ishimoto J, Trujillo TC, Kiser T. Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples. Am J Clin Pathol 2014;141:665-74.
• Lose J, Dorsch MP, DiDomenico RJ. Differences in practice patterns between inpatient cardiology pharmacists with Board of Pharmaceutical Specialties Added Qualifications in Cardiology compared to pharmacists without this distinction. Hosp Pharm. In press.
• Lu L, Krumholz HM, Tu J, Ko DK, Ross J, Jackevicius CA. Impact of drug policy on regional trends in ezetimibe use. Circ Cardiovasc Qual Outcomes 2014;7:589-96.
• Lu L, Krumholz HM, Tu J, Ross J, Ko DK, Jackevicius CA. Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada. Am Heart J 2014;167:683-9.
• McConnell KJ. Cardiology II. In: Bainbridge JL, Coyle EA, Forinash AB, et al. Updates in Therapeutics®: The Ambulatory Care Preparatory Review and Recertification Course, 2014 ed. Lenexa, KS: American College of Clinical Pharmacy, 2014:1-671–1-740.
• McConnell KJ, Stadler SL. Update on the therapeutic management of hypertension. In: Dong BJ, Elliott DP, eds. Ambulatory Care Pharmacy Self-Assessment Program, 2014 Book 2. Cardiology Care. Lenexa, KS: American College of Clinical Pharmacy, 2014:10-32.
• McGuire TR, Kalil AC, Dobesh PP, Klepser DG, Olsen KM. Anti-inflammatory effects of rosuvastatin in healthy subjects: a prospective longitudinal study. Curr Pharm Des 2014;20:1156-60.
• Miller MP, Trujillo TC, Nordenholz KE. ED management of bleeding in the setting of target specific oral anticoagulants. Am J Emerg Med 2014;32:375-82.
• Misky G, Carlson T, Thompson E, Trujillo T, Nordenholz K. Implementation of an acute venous thromboembolism clinical pathway reduces health care utilization and mitigates health disparities. J Hosp Med 2014. http://onlinelibrary.wiley.com/doi/10.1002/jhm.2186/pdf.
• Morris PB, Ballantyne CM, Birtcher KK, Dunn SP, Urbina EM. Review of clinical practice guidelines for the management of LDL-related risk. J Am Coll Cardiol 2014;64:196-206.
• Murphy MV, Du D, Hua W, Butler MG, Davis RL, Johnson L, Nakasato C, Nordin JD, Ramesh M, Schum M, von Worley A, Zinderman C, Platt R, Klompas M. The utility of claims data for anterior cruciate ligament infection surveillance. Infect Control Hosp Epidemiol 2014;35:652-9.
• Ng TMH, Ackerbauer K. Heart failure. In: Dong BJ, Elliott DP, eds. Ambulatory Care Pharmacy Self-Assessment Program, 2014 Book 2. Cardiology Care. American College of Clinical Pharmacy, 2014.
• Ng TMH, Cao DX, Patel KA, Wong YM, Prasad M, Lou M, Elkayam U. Hyponatremia is associated with diuretic resistance and a higher incidence of worsening renal function in patients with acute decompensated heart failure. Cardiology 2014;128:333-42.
• Norrid SB, Oliphant CS. Colchicine for the treatment of acute and recurrent pericarditis. Ann Pharmacother 2014;48:1050-4.
• Nutescu EA, Bathija S, Chan J, Engle J, Grim S, Mucksavage J, Ohler K, Shapiro NL, Tesoro E, DiDomenico RJ. Balance of academic responsibilities of clinical track pharmacy faculty. Pharmacotherapy. In press.
• Oestreich JH, Best LG, Dobesh PP. Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans. Am Heart J 2014;167:413-8.
• Oestreich JH, Dobesh PP. Cangrelor for treatment during percutaneous coronary intervention. Future Cardiol 2014;10:201-13.
• Oliphant CS, McCullough J, Hashim T, Khouzam RN. Vitamin K antagonist use for all patients with hypertrophic cardiomyopathy and atrial fibrillation: analysis of the literature and guideline review. Future Cardiol 2014;10:229-33.
• Oliphant CS, Twilla JD. Impact of a pharmacist on compliance with hospital core measures. J Pharm Pract 2014;27:379-83.
• Parker MH. Stroke prevention in atrial fibrillation. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program, 2014 Book 2. Cardiology Care. Lenexa, KS: American College of Clinical Pharmacy, 2014:146-67.
• Parra D, Hough A. Current therapeutic approaches to cardio-protection in hypertension. Curr Hypertens Rep 2014;16:1-12.
• Perugu S, Rehan V, Chow SL, Baylen B. Plasma biomarkers and echocardiographic indices of left ventricular function in very low birth weight infants. J Neonatal Perinatal Med. In press.
• Pon TK, Dager WE, Roberts AJ, White RH. Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients. Thromb Res 2014;133:1023-8.
• Raebel MA, Ellis JL, Schroeder EB, Xu S, O’Connor PJ, Segal JB, Butler MG, Schmittdiel JA, Kirchner HL, Goodrich GK, Lawrence JM, Steiner JF. Intensification of antihyperglycemic therapy among patients with incident diabetes: a SUrveillance PREvention and ManagEment of Diabetes Mellitus (SUPREME-DM) study. Pharmacoepidemiol Drug Saf 2014;23:699-710.
• Rollins BM, Siva MA, Donovan JL, Kanaan AO. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison; meta-analysis approach. Clin Ther 2014 Aug 1. [Epub ahead of print]
• Sakaan SA, Hudson JQ, Oliphant CS, Tolley EA, Cummings C, Alabdan NA, Self TH. Evaluation of warfarin dose requirements in patients with chronic kidney disease and end-stage renal disease. Pharmacotherapy 2014;34:695-702.
• Schmittdiel JA, Dyer W, Uratsu C, Magid D, O’Conner PJ, Beck A, Butler MG, Ho M, Vasquez-Benitz G, Adams AS. Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression. J Clin Hypertens (Greenwich) 2014;16:412-7.
• Schmittdiel JA, Raebel MA, Dyer W, Xu S, Goodrich GK, Schroeder EB, Segal JB, O’Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Karter AJ, Lafata JE, Butler MG, Steiner JF. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014;54:374-82.
• Tisdale JE. Can I get a guideline to help me interpret treatment guidelines? Can J Hosp Pharm 2014;67:181-2.
• Tisdale JE. What causes some patients with drug-induced QT-interval prolongation to develop torsades de pointes but not others? The elusive missing link. Drugs Aging 2014;31:577-9.
• Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN, Kovacs RJ. Effectiveness of a clinical decision support system for reducing the risk of QT-interval prolongation in hospitalized patients.Circ Cardiovasc Qual Outcomes 2014;7:381-90.
• Tjia J, Field T, Lemay C, Mazor K, Pandolfi M, Spenard AN, Ho SY, Kanaan A, Donovan J, Gurwitz JH. Antipsychotic use varies in nursing homes by psychiatric consultant. Med Care 2014;52:267-71.
• Trujillo TC, Dobesh P. Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications. Drugs. In press.
• Tuteja S, Rader DJ. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm. Clin Pharmacol Ther 2014;96:48-56.
• Waite L, Phan YL, Spinler S. Cangrelor: a novel antiplatelet agent with a questionable future. Pharmacotherapy 2014 Aug 13.
• Xu S, Schroeder EB, Shetterly S, Goodrich GK, O’Connor PJ, Steiner JF, Schmittdiel JA, Desai J, Pathak RD, Neugebauer R, Butler MG, Kirchner L, Raebel MA. Accuracy of hemoglobin A1c imputation using fasting plasma glucose in diabetes research using electronic health records data. SOIC 2014;2:93-104.

Posters/Abstracts Presented:

• Jiang WJ, Phan P, Baker B, Chow SL. C-reactive protein does not predict therapeutic response in patients with heart failure: a meta-analysis. Poster presented at: ACC Scientific Sessions; March 29, 2013; Washington, DC. JACC 2014;63:A189.
• Lu L, Jackevicius CA, De Leon N, Warner A, Chang D, Mody FV. Impact of a multi-disciplinary heart failure post-discharge management clinic on medication adherence. Poster presented at: Abstract of American College of Cardiology (ACC) 2014 Scientific Session; 2014; Washington, DC. (Awarded ACC CV Team Best Poster)
• Lu L, Krumholz HM, Tu J, Ko DK, Ross J, Jackevicius CA. Impact of drug policy on regional trends in ezetimibe use. Presented at: Abstract of American Heart Association Quality of Care and Outcomes Research (AHA/QCOR) Meeting; 2014; Baltimore, MD. (Invited for representation as a poster at AHA Scientific Session 2014)

The following PRN members were elected as new ACCP Fellows:

• Rhonda Cooper-DeHoff
• Cynthia Jackevicius
• Joel Marrs
• Mary Parker
• Mary Beth Shirk
• Jessica Staff
• Orly Vardeny

Other Notable Achievements:

• William Baker: University of Connecticut School of Pharmacy 2014 Teacher of the Year
• Mike Dorsch and Barry Bleske published an iOS app for the education of patients with heart failure, named ManageHF (https://itunes.apple.com/us/app/managehf/id898845558?mt=8). Publication: “Identification of Adverse Drug Events Post-hospital Discharge in a Geriatric Population.” Reviewed by S.A. Brett, who also interviewed Abir Kanaan—Adverse drug events are common just after hospitalization— Engl J Med Journal Watch Audio: General Medicine, January 9, 2014. Available at www.jwatch.org/na33302/2014/01/09/adverse-drug-events-are-common-just-after-hospitalization. Accessed April 4, 2014. Featured by: What ADEs Are Common After Hospital Discharge in Older Adults? The publication was also recognized by Medscape Pharmacists MedPulse: Top Stories, December 10, 2013.

The Clinical Administration PRN continues to grow and is now at an all-time high of 459 members. The PRN has been actively engaged in committees, including the Nominations, Travel Awards, and Annual Meeting Focus Session Planning committees.

This year, the Clinical Administration PRN offered two new travel scholarships of $500 each. The Clinical Administration PRN Travel Award is intended to provide partial financial support for students, residents, or fellows interested in administrative career paths to attend the 2014 ACCP Annual Meeting.

The Annual Meeting Focus Session Planning Committee developed a focus session in which experts from around the country will share how they have successfully employed pharmacy students in innovative ways to improve key performance indicators.

Promotions

• David L. Lourwood, Pharm.D., FCCP, BCPS, was promoted to adjunct clinical associate professor of pharmacy practice by the St. Louis College of Pharmacy and the School of Pharmacy at the University of Missouri-Kansas City.

Grants

• Elizabeth Michalets
• Landers A, Michalets E, DeJong D; American Society of Health-System Pharmacists (ASHP) Residency Expansion Grant for PGY2 in Emergency Medicine; 2014–2015
• Michalets E, Rafferty A, Sutherland S, Arledge J; American Society of Health-System Pharmacists (ASHP) Practice Model Grant; “Pharmacist-Provided Medication Management in Interdisciplinary Transitions (PMIT),” 2014–2015

Publications

• Elizabeth Michalets: Conger M, Oramasionwu C, Duffey K, Bailey SC, Shilliday BB, Brown L, Denslow S, Michalets E. Impact of health literacy on time in therapeutic range for outpatients on warfarin: preliminary data. Abstract and poster presented at: Health Literacy Research Conference (HARC); Washington, DC.
• Elizabeth Michalets: Tilton R, Michalets EL, Delk B, Ramming S. Outcomes associated with prothrombin complex concentrate for international normalized ratio reversal in patients on oral anticoagulants with acute bleeding. Ann Pharmacother 2014; published ahead of print June 5, 2014. http://aop.sagepub.com/cgi/reprint/1060028014537897v1.pdf?ijkey=SixREbdHczphRIn&keytype=ref
• John Noviasky: Noviasky J, Pierce DP, Whalen K, Guharoy R, Hildreth K. Bupivacaine liposomal versus bupivacaine: comparative review. Hosp Pharm 2014;49:539-43.

Notable Achievements

• Richard J. Artymowicz, Pharm.D., MBA, FCCP, BCPS, received a master’s degree in business administration from Rutgers University in May. Dr. Artymowicz serves as the director of pharmacy services and administrative director of cardiac, respiratory, and sleep services at Cape Regional Medical Center in Cape May Court House, New Jersey.
• Angela Smith, Pharm.D., MHA, BCPS, graduated in August from Pfeiffer University with a master’s degree in health care administration.

The various Critical Care PRN committees include the Recognition; Program; Student, Resident, and Fellow; Awards; Research; and Communication committees. These committees have made significant progress in achieving their respective charges. The Communication Committee has already published a critical care newsletter informing our PRN membership of current activities and opportunities to become involved. The Travel and Research committees have sent out a call to the membership for various awards and grant opportunities. In addition, many of our PRN members have received various awards and promotions and made other notable achievements.

Promotions:

• Drayton A. Hammond: Clinical assistant professor at University of Arkansas for Medical Sciences
• Eric Mueller: Assistant director, Clinical Pharmacy Services and Research, University of Cincinnati Medical Center
• Farzana Musawwir: Critical care clinical pharmacist at UM BWMC

Awards:

• Scott Bolesta: Society of Critical Care Medicine Presidential Citation
• Mitchell S. Buckley: Fellow of the American Society of Health-System Pharmacists
• Mason Bucklin: ACCP EMED PRN Resident Travel Award
• Alexander H. Flannery: Kentucky Society of Health-System Pharmacists Resident of the Year
• Erin Frazee: Mayo Clinic New Preceptor of the Year Award
• Drayton A. Hammond: Florida Residency Conference PGY2 Excellence in Research Award
• Sara Jordan: ACCP Virtual Poster Symposium Best Poster
• Stacey Moultrie: UF Health Shands Children’s Hospital Medication Safety Good Catch Award
• Farzana Musawwir: Special recognition from American Society of Bangladeshi Pharmacists (AABPS) for clinical accomplishment

Grants:

• Leslie Hamilton: University of Tennessee College of Pharmacy Scholarship of Teaching and Learning Seed Grant, 2013, principal investigator
• Eric Mueller: U.S. Air Force FA8650-10-2-6140 proposal
• Antonia (Toni) Vilella: Grant from AdvanDX to complete the MAD-ID Advanced Antimicrobial Stewardship Program Certificate

Publications:

• Anger KE. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit. Curr Pharm Des 2013;19:4003-13.
• Anger KE, Adams CD, Greenwood BC, Fanikos J. Antithrombotic therapy in critically ill patients. In: Irwin and Rippe’s Manual of Intensive Care Medicine, 6th ed. New York: Wolters Kluwer, 2014:664-89.
• Anger KE, Belisle C, Colwell MB, Dannemiller R, Alawadhi B, Wilkocki A, Szumita PM. Safety of compounded calcium chloride admixtures for peripheral intravenous administration in the setting of a calcium gluconate shortage. J Pharm Pract 2014.
• Anger KE, Degrade JR, Greenwood BC, Cohen SA, Szumita PM. Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center. Ther Clin Risk Manag 2013;9:277-84.
• Beik N, Anger KE, Forni AF, Bawa K, Szumita PM. Evaluation of a guideline for hyperglycemic emergencies at a tertiary academic medical center. Ann Pharmacother 2013;47:1260-5.
• Reardon DP, Anger KE, Adams CD, Szumita PM. Evaluating the role of dexmedetomidine in adult patients in the intensive care unit: updated review. Am J Health Syst Pharm 2013;70:767-77.
• Reardon DP, Degrade JR, Anger KE, Szumita PM. Early vasopressin reduces incidence of new onset arrhythmias. J Crit Care 2014.
• Sylvester K, Fanikos J, Anger KE, Matta L, Southard RA, Beik N, Lemire S, Dorfman DM, Berliner N. Testing for heparin-induced thrombocytopenia: enzyme-linked immunosorbent assay impacts management. Pharmacotherapy 2013;33:1191-8.
• Torbic H, Forni AA, Anger KE, Degrade JR, Greenwood BC. Use of antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health Syst Pharm 2013;70:759-66.
• Torbic H, Forni AA, Anger KE, Degrade JR, Greenwood BC. Antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health Syst Pharm 2013;70:2064-7.
• Torbic H, Szumita PM, Anger KE, Nuccio P, LaGambina S, Weinhouse G. Inhaled epoprostenol versus inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care 2013;28:844-8.
• Birrer KL. Pain, agitation, and delirium in the ICU. In: Murphy JE, Lee MWL. eds. Pharmacotherapy Self-Assessment Program, 2014 Book 1. Critical and Urgent Care II. Lenexa, KS: ACCP, 2014:177-97.
• Bayouth L, Safcsak K, Cheatham ML, Smith CP, Birrer KL, Promes JT. Early intravenous ibuprofen decreases narcotic requirement and length of stay following traumatic rib fracture. Am Surg 2013;79:1207-12.
• Bolesta S. Acute kidney injury. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 9th ed. New York: McGraw-Hill, 2014:157-8.
• Bolesta S, Montgomery PA. Pancreatitis. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 9th ed. New York: McGraw-Hill, 2014:565-82.
• Buckley MS, Berry AJ, Kazem NH, Patel SA, Librodo PA. Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review. Core Evid 2014;9:71-80.
• Bucklin MH, Acquisto NM, Nelson C. The effects of recombinant activated factor VII dose on the incidence of thromboembolic events in patients with coagulopathic bleeding. Thromb Res 2014;133:768-71.
• Bucklin MH, Gorodetsky RM, Wiegand TJ. Prolonged lipemia and pancreatitis due to extended infusion of lipid emulsion in bupropion overdose. Clin Toxicol 2013;51:896-8.
• Bucklin MH, Groth CM. Mortality following rasburicase-induced methemoglobinemia. Ann Pharmacother 2013;47:1353-8.
• Engle JP, Erstad BL, Anderson DC, Bucklin MH, Chan A, Donaldson AR, Hagemann TM, Rodgers PT, Schwinghammer T, Tennant S, Thomas Z. Minimum qualifications for clinical pharmacy practice faculty. Pharmacother 2014;34:e38-e44.
• Flannery AH, Flynn JD. More questions than answers in ICU delirium: pressing issues for future research. Ann Pharmacother 2013;47:1558-61.
• Flannery AH, Hatton KW, Phillips B. Sedation and delirium in intensive care. N Engl J Med 2014;370:1566-7.
• Flannery AH, Thompson Bastin ML. Oseltamivir dosing in critically ill patients with severe influenza. Ann Pharmacother 2014 May 9.
• Flynn JD, McConeghy KW, Flannery AH, Nestor M, Branson P, Hatton KW. Utilization of pharmacist responders as a component of a multidisciplinary sepsis bundle. Ann Pharmacother 2014 Jun 5.
• Frazee EN, Nystrom EM, McMahon MM, Williamson EE, Miles JMM. Relationship between triglyceride tolerance, body mass index, and fat depots in hospitalized patients receiving parenteral nutrition. J Parenteral Enteral Nutr 2014.
• Frazee EN, Rule AD, Herrmann SM, Kashani KB, Leung N, Virk A, Voskoboev N, Lieske JC. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study. Crit Care 2014.
• Leedahl DD, Frazee EN, Schramm GE, Dierkhising RA, Bergstralh EJ, Chawla LS, Kashani KB. Derivation of urine output thresholds that identify a very high risk of AKI in patients with septic shock. Clin J Am Soc Nephrol 2014.
• Personett H, Larson S, Frazee EN, Nyberg S, Leung N, El-Zoghby ZM. The impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report. Transplant Proc 2014.
• Hamilton LA, Abbott GV, Cooper JB. High-risk non-ST elevation acute coronary syndrome outcomes in patients treated with unfractionated heparin monitored using anti-Xa concentrations versus activated partial thromboplastin Time. Hosp Pharm 2013;48:38.
• Hammond DA, DeRemer CE, Killough DM, Berman A. Intermediate-dose enoxaparin after cardiac ablation procedures. JHC 2014.
• Hammond DA, Norris KR, Phillips MS. Embracing challenges when co-precepting pharmacy students. Hosp Pharm 2014;49:348-54.
• Hammond DA, Tan S, DeLosSantos M. Letter to the editor on use of ranolazine in the prevention and treatment of postoperative atrial fibrillation in patients undergoing cardiac surgery. Ann Pharmacother 2014.
• Alhazzani W, Jacobi J, Sindi A, et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2013;41:1555-64.
• Johnson PN, Benefield EC, Bui PN, Gausaman JN, Marlar RA, Gessouroun M. Fondaparinux monitoring: need for a local fondaparinux calibrated anti-factor Xa assay. J Pediatr Pharmacol Ther 2013;18:318-9.
• Johnson PN, Benefield EC, Bui PN, Marlar RA, Gessouroun M. Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failure. J Pediatr Pharmacol Ther 2013;18:303-10.
• Johnson PN, Miller JL, Hagemann TM, Castro C, Harrison D. External validation of the Medication Taper Complexity Score for methadone tapers in children with opioid abstinence syndrome. Ann Pharmacother 2014;48:187-95.
• Andrews MA, Johnson PN, Lammers EM, Harrison DL, Miller JM. Acetazolamide in critically ill neonates and children with metabolic alkalosis. Ann Pharmacother 2013;47:1130-5.
• Andrews MA, Miller JL, Allen C, Hagemann TM, Harrison DL, Johnson PN. Implementation of a bowel regimen in critically ill children: a pilot study. J Pediatr Intensive Care 2013;2:63-9.
• Cottrell M, Rathbun C, Webb R, Johnson PN, Lockhart S. Implications for hepatitis C treatment and disease progression in an HIV/HCV co-infected population. J Virol Antivir Res.
• Lammers EM, Johnson PN, Ernst KD, Hagemann TM, Lawrence SM, Williams PK, Anderson MP, Miller JM. Association of continuous infusion fentanyl on neurodevelopmental outcomes in very low birth weight infants. Ann Pharmacother 2014;48:335-42.
• Miller JL, Schaefer J, Tam M, Harrison D, Johnson PN. Ethacrynic acid continuous infusions in pediatric patients. J Pediatr Pharmacol Ther 2014;19:50-6.
• Miller JM, Thomas AN, Johnson PN. Continuous infusions of loop diuretics in critically ill children. Pharmacotherapy.
• Logan JK, Pantle H, Huiras P, Bessman E, Bright L. Evidence-based diagnosis and thrombolytic treatment of cardiac arrest or periarrest due to suspected pulmonary embolism. Am J Emerg Med 2014;32:789-96.
• Elsoueidi R, Craig J, Mourad H, Richa EM. Safety and efficacy of FOLFOX followed by cetuximab for metastatic colorectal cancer with severe liver dysfunction. J Natl Compr Canc Netw 2014;12:155-60.
• Elsoueidi R, Mulat A, Mourad H. Bendamustine treatment in a heavily pretreated Hodgkin lymphoma patient. J Oncol Pharm Pract 2014 May 19.
• Brown A, Sangha K, Mueller EW, Kaur D, Keegan S. Letter on: Kane S, Bress AP, Tesoro EP. Characterization of unbound phenytoin concentrations in neurointensive care unit patients using a revised Winter-Tozer equation. Ann Pharmacother.
• Droege ME, Mueller EW, Hanseman DJ, Besl KM, Lemmink JA, Kramer EA, Athota KP, Droege CA, Ernst NE, Keegan SP, Lutomski DM, Robinson BRH. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients. J Trauma Acute Care Surg 2014;76:450-6.
• Moore ME, Mueller EW. Aerosolized antibiotic therapy: a forward aerial assault or forced contingency for ventilator-associated pneumonia? Respir Care 2012;57:1348-9.
• Moore ME, Mueller EW, Robinson BRH. Clinical pharmacology. In: Ashley S, Wilmore DW, Klingensmith ME, et al., eds. ACS Surgery: Principles and Practice. Chicago: BC Decker, 2011:chap 23.
• Robinson BRH, Blakeman T, Toth P, Hanseman DJ, Mueller EW, Branson R. Patient-ventilator asynchrony in a traumatically injured population. Respir Care March 2013.
• Rech MA, Fleming JN, Moore CL. 25-Hydroxyvitamin D deficiency predicts incidence of opportunistic viral infections after kidney transplantation. Exp Clin Transplant 2014;2:95-100.
• Rech MA, Hunsaker T, Rodriguez J. 25-Hydroxyvitamin D deficiency predicts 30-day mortality in patients with severe sepsis and septic shock. Am J Crit Care. In press.
• Rech MA, To L, Tovbin A, et al. Heavy metal in the ICU: a review of current literature on trace element supplementation in critically ill patients. Nutr Clin Pract 2014;29:78-89.
• Bauman ZM, Killu K, Rech MA, et al. Racial differences in vasopressor requirements for septic shock. Shock 2014;41:188-92.
• Vilella AL, Limsuwat C, Williams DR, Seifert CF. Cholestatic jaundice as a result of combination designer supplement ingestion. Ann Pharmacother 2013;47:e33.
• Vilella AL, Seifert CF. Timing and appropriateness of initial antibiotic therapy in newly presenting septic patients. Am J Emerg Med 2014;32:7-13.
• Wood GC, Boucher AB, Johnson JL, Wisniewski JN, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC. Effectiveness of pseudoephedrine as adjunctive therapy for neurogenic shock after acute spinal cord injury: a case series. Pharmacotherapy 2014;34:89-93.
• Wood GC, Swanson JM. Hypovolemic shock. In: Katz M, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach, 3rd ed. New York: McGraw-Hill, 2013:55-8.
• Boucher BA, Wood GC. Acute management of the brain injury patient. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 9th ed. New York: McGraw-Hill, 2014:895-910.
• Monteen MR, Ponnapula S, Wood GC, Croce MA, Swanson JM, Boucher BA, Fabian TC. Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient: a case report. Ann Pharmacother 2013;47:1736-9.
• Ponnapula S, Swanson JM, Wood GC, Boucher BA, Wells DL, Croce MA, Fabian TC. Treatment of Rhizobium radiobacter bacteremia in a critically ill trauma patient. Ann Pharmacother 2013;47:1584-7.

New ACCP Fellows:

• Mitchell S. Buckley, Pharm.D., FCCM, BCPS
• Anthony T. Gerlach, Pharm.D., FCCM, BCPS

Other Notable Achievements:

• Scott Bolesta: Fellow of Critical Care Medicine and member-at-large, Research Section, Society of Critical Care Medicine
• Erin Frazee: SCCM CPP Research Committee Chair
• Leslie Hamilton: Chair, AACP Pharmacy Practice Awards Committee
• Drayton A. Hammond: Board Certified Pharmacotherapy Specialist
• Judith Jacobi: ACCP president-elect
• Pete Johnson: PGY2 Pediatric Pharmacy Residency Program director at University of Oklahoma College of Pharmacy; Advocacy Committee chair with Pediatric Pharmacy Advocacy Group; and member of the ASHP Pediatric Specialty Examination Review Course
• Sara Jordan: Board Certified Pharmacotherapy Specialist
• Jill Logan: American Society of Health-System Pharmacists New Practitioner Forum, Pharmacy Advisory Group 2012–2013
• Hesham Mourad: Board Certified Pharmacotherapy Specialist and House of Delegates-Kentucky Society of Health-System Pharmacists
• Eric Mueller: Chair, ACCP Fellowship Review Committee, and section writer, Pharmacy Residency Expansion Grant, University of Cincinnati Medical Center, American Society of Health-System Pharmacists Foundation, 2013
• Farzana Musawwir: Board Certified Pharmacotherapy Specialist and service on an academic task force for American Society of Bangladeshi Pharmacists (AABPS)
• Alia Poore: OCCP Planning Committee co-chair
• Megan Rech: Board Certified Pharmacotherapy Specialist, Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Research charge leader, Literature Update Publications
• Nikhat Syed: Added Qualifications in Cardiology
• Chris Wood: Regent of ACCP

Other:

• Stacey Moultrie: NIH Training Certificate of Course Completion and University of Florida College of Pharmacy portfolio mentor
• Nikhat Syed: Earned MBA from NC State University
• Chris Wood: Chosen to attend the 2013 ACCP FIT Program (received the ID PRN scholarship)

Promotions:

• Hanrahan C. Drug information specialist at Intermountain Healthcare; previously PGY2 drug information resident at the Medical University of South Carolina

Awards:

• Phillips J. Outstanding Advisor Award, Midwestern University Student Senate

Publications:

• Bryson ML. Insomnia: focus on new dosing concerns in women. Pract Pain Manage 2014;14:45-53. Available at www.practicalpainmanagement.com/resources/clinical-practice-guidelines/insomnia-focus-new-dosing-concerns-women.
• Bryson ML, Kean N. New dosing for Lunesta cuts next-day “hangover” effect. Pract Pain Manage May 19, 2014. Available at www.practicalpainmanagement.com/patient/treatments/medications/new-dosing-lunesta-cuts-next-day-hangover-effect.
• Cogdill BR, Ross CA, Hurst JM, Garrison KL, Drayton SJ, Wisniewski CS. Evaluation of urinalyses ordered for diagnosis of urinary tract infections at an inpatient psychiatric hospital. Int J Psychiatry Med 2014;47:17-24.
• Davies ML, Johnson MD, Brown JN, Bryan WE, Townsend ML. Predictors of glycemic control among HIV-positive veterans with diabetes. Int J STD AIDS 2014 May 14. [Epub ahead of print]
• Galanter WL, Bryson ML, Falck S, et al. Indication alerts intercept drug name confusion errors during computerized entry of medication orders. PLoS One 2014;9:e101977.
• Glaholt S, Hayes GL, Wisniewski CS. Evaluation of discharge medication orders following automatic therapeutic substitution of commonly exchanged drug classes. P T 2014;39:267-72.
• Hanrahan C, Aungst TD, Cole S. Evaluating Mobile Medical Applications [Internet]. ASHP eReport. Bethesda, MD: American Society of Health-System Pharmacists, 2014. Available at http://ebooks.ashp.org/catalog/show/ashp+ereports/12.
• Hanrahan C, Cole SW. Assessment of drug information resource preferences of pharmacy students and faculty. J Med Libr Assoc 2014;102:117-21.
• Hanrahan C, New JP. Antidepressant medications: the FDA-approval process and the need for updates. Ment Health Clin 2014;4:45.
• Lindquist D, Cruz J, Brown JN. Use of erythropoiesis-stimulating agents in the treatment of anemia in patients with systolic heart failure. J Cardiovasc Pharmacol Ther 2014 Jul 3. [Epub ahead of print]
• McLaughlin MM, Skoglund E, Gettig JP. Residency information preferences of recent pharmacy residency applicants. J Pharm Technol 2014 Jun 19. [Epub ahead of print]
• Patil A, Patil N, Lewis A, Swamy G, Murtha A. Healthcare providers’ use of a drug information service (DIS) for pregnancy related inquiries. J Am Pharm Assoc (2003). In press.
• Peters S, Pappas A. Effects of bisphosphonate use on fetal outcomes. Am J Health Syst Pharm. In press.
• Phillips J, Lam C, Palmisano L. Analysis of the accuracy and readability of herbal supplement information on Wikipedia. J Am Pharm Assoc (2003) 2014;54:406-14.
• Prasad B, Bryson ML. Insomnia treatments. Pract Pain Manage 2014 Jun 12. Available at www.practicalpainmanagement.com/patient/conditions/insomnia/insomnia-treatments.
• Schneider K, Phillips J. Lutein and zeaxanthin for age-related macular degeneration. Ill Pharm 2014;76:33-5.
• Thornby K, Johnson A, Axtell S. Dornase alfa for non-cystic fibrosis pediatric pulmonary atelectasis. Ann Pharmacother 2014;48:1040-9.
• Wright EA, Brown B, Gettig J, et al. Teaching and learning curriculum programs: recommendations for postgraduate pharmacy experiences in education. Am J Health Syst Pharm 2014;71:1292-302.
• Zullig LL, Pathman J, Melnyk SD, Brown JN, Sanders LL, Koropchak C, Howard T, Danus S, McCant F, Bosworth HB. A protocol to evaluate the efficacy, perceptions, and cost of a cholesterol packaging approach to improve medication adherence. Contemp Clin Trials 2014 Aug 10. [Epub ahead of print]

Other Notable Achievements:

• Bryson ML. Design and implementation of an algorithm to detect look-alike/sound-alike medication errors: a pilot study. Poster presented at: American Society of Health-System Pharmacists Summer Meeting; June 2, 2014; Las Vegas, NV.
• Bryson ML. Adherence management: expanding the role of the pharmacist and technician. Co-presented a 90-minute session at: Thoughtspot 2014 AmerisourceBergen Annual Tradeshow; July 30, 3014; Las Vegas, NV.
• Bryson ML. Prevention of drug name confusion errors—an unexpected side effect of CPOE indication alerts. Presented at: Informatics Pearls 2013 Session. American Society of Health-System Pharmacists Midyear Clinical Meeting; December 12, 2013; Orlando, FL.
• Pappas A. Contributing author to Pharmacy Times Health-System edition and submits six formulary drug reviews each year
• Pappas A. Invited presentation for the American Association of Critical Care Nurses (AACN)

The Education and Training PRN has grown to more than 560 members who continue to advance the PRN’s mission of promoting dialogue and interaction to develop programs that enhance the knowledge and skills needed to provide education and training within clinical pharmacy. The PRN is happy to share the many accomplishments of its members and looks forward to another busy year.

First, we would like to welcome Joshua Caballero, Pharm.D., BCPP, as our incoming chair-elect and Laura Tsu, Pharm.D., BCPS, CGP, as our incoming secretary/treasurer. Dr. Caballero is an associate professor at Nova Southeastern University. Dr. Tsu is an assistant professor - pharmacy practice, Midwestern University - College of Pharmacy Glendale. We look forward to working with them. Sarah Nisly, Pharm.D., BCPS, will move from serving as chair-elect to chair for the upcoming year, and Kristi Kelley, Pharm.D., FCCP, BCPS, CDE, will serve an additional year as past chair. We want to thank Samantha Karr, Pharm.D., BCPS, BCACP, for her leadership and commitment to the PRN as she completes her service as past chair. Thank you, Dr. Karr, for all of your hard work!

The EDTR PRN will once again host the mock interviews for students and residents during the 2014 Annual Meeting in Austin immediately after the business meeting and networking forum on Monday, October 13, at 6 p.m. During the 2013 Annual Meeting, 52 interviewees took advantage of this opportunity to learn key interviewing skills from clinical faculty and practitioners in preparation for residency or initial career position interviews. Thirty-seven interviewers graciously volunteered their time to make this event a success. Most participants were able to go through two rounds of mock interviews to receive valuable feedback from several interviewers. We look forward to offering this activity at the upcoming meeting and ask that you encourage students and residents attending the meeting to take advantage of this opportunity.

The Student and Postgraduate Trainee Support Committee has had a busy and productive year, from providing support to the StuNet Advisory Committee to expanding the EDTR PRN Travel Scholarship to three awards, thanks in part to the success of the PRN’s first annual silent auction held during its annual business meeting. The recipients will be recognized in Austin at the PRN business meeting, where they will provide a short presentation. Please come by to support our winners and future colleagues. A special thanks to Michelle Musser, Pharm.D., BCPS; Heather Pentecost, Pharm.D.; James Scott, Pharm.D., FCCP; Andrew Smith, Pharm.D., BCPS; Yasar Tasnif, Pharm.D., BCPS;;Laura Tsu, Pharm.D., BCPS; Alana Whittaker, Pharm.D.; and Nancy Yunker, Pharm.D., BCPS, for their work on the Selection Committee.

The PRN is pleased to recognize two of its members who were participants in this year’s FIT Program as part of ACCP’s Research Institute: Daniel Riche, Pharm.D., BCPS, CDE; and Kayla Stover, Pharm.D., BCPS (AQ-ID), both with the University of Mississippi. The PRN voted to cover half tuition earlier this year. Both Drs. Riche and Stover received support from additional PRNs to cover their tuition for their participation. Dr. Stover received full tuition from the ID PRN, and Dr. Riche received half tuition from the Ambulatory Care PRN and the remaining half from the EDTR PRN. We are delighted to recognize these two members and their ongoing research. Dr. Riche’s research involves dietary supplements and hypertension. Dr. Stover’s research interest is in the area of antifungal pharmacotherapy. Both recipients will take a few moments to share their experiences with the FIT Program during our annual PRN business meeting in Austin. We look forward to learning more and encouraging our PRN members to participate in the future!

Don’t forget that the Scholarly Activities Committee has sponsored an enduring program on YouTube created specifically for the EDTR PRN, “Primer on Psychometric Issues with Educational Testing,” by Michael J. Peters, Pharm.D., MEd, BCPS. The program can be accessed by the link available through the PRN homepage. Continue to watch the e-mail list for information concerning additional programs to be offered in the future.

The EDTR PRN is proud of its growing membership and wants to continue to expand. We encourage ACCP members who are interested in promoting our mission to join the EDTR PRN.

Promotions:

• Emily Flores, Pharm.D., BCPS, was promoted to associate professor within the Department of Pharmacy Practice at Gatton College of Pharmacy.
• Katie McClendon, Pharm.D., BCPS, was promoted to clinical associate professor in addition to being appointed assistant dean for student services - Jackson Campus and director of student affairs for the Department of Pharmacy Practice with the University of Mississippi School of Pharmacy.
• Sarah A. Nisly, Pharm.D., BCPS, was promoted to associate professor of pharmacy practice at Butler University College of Pharmacy and Health Sciences.
• Francine Salinitri, Pharm.D., was promoted to associate professor of (clinical) pharmacy practice at Wayne State University.

Awards:

• Andrew Bzowyckyj, Pharm.D., BCPS, CDE, from the University of Missouri-Kansas City School of Pharmacy, received an AADE Pharmacy Best Practices in Diabetes Care Award from the American Association of Diabetes Educators for 2014.
• Marshall E. Cates, Pharm.D., FASHP, BCPP, was awarded Teacher of the Year in May 2014 for Samford University McWhorter School of Pharmacy.
• Alexander H. Flannery, Pharm.D., BCPS, was named Kentucky Society of Health-System Pharmacists Resident of the Year in October 2013.
• Kelly Hester, Pharm.D., BCPS; Kristi Kelley, Pharm.D., FCCP, BCPS, BC-ADM, CDE; and Dana Carroll, Pharm.D., BCPS, were awarded the Auburn University Harrison School of Pharmacy’s inaugural Excellence in Teaching Award as part of a teaching team. All were recognized as Teachers of the Year at the 2014 AACP Annual Meeting.
• Sarah Treadway, Pharm.D., BCPS, was selected as the 2014 Outstanding Faculty Member by the Auburn University Harrison School of Pharmacy SGA.

Publications:

• Sandra Benavides, Pharm.D.
  • Benavides S, Phan H, Nahata MC, eds. Pediatric Pharmacotherapy Self-Assessment. Bethesda, MD: American Society of Health-System Pharmacists; anticipated release September 15, 2014.
  • Dr. Benavides not only served as lead editor for the book, but also wrote or cowrote several cases and chapters related to nutrition, nephrotic syndrome, diabetic ketoacidosis, type 2 diabetes mellitus, and hypothyroidism in pediatric patients.
• Cassandra Benge, Pharm.D., BCPS (AQ-CV)
  • Baker JW, Bean JB, Benge C, McFarland MS. Designing a resident research program. Am J Health Syst Pharm 2014;71:592-8.
• Tina Denetclaw, Pharm.D., BCPS
  • Denetclaw TH, Nguyen MT. Patient failure to seek care for non-ST-elevated myocardial infarction because of symptoms being attributed to dyspepsia from dabigatran. Ann Pharmacother 2014;48:1093-4.
  • Denetclaw TH, Suehiro I, Wang PK, Tolliver GL. Successful treatment of ventriculostomy-associated meningitis caused by multidrug resistant coagulase-negative Staphylococcus epidermidis using low-volume intrathecal daptomycin and loading strategy. Ann Pharmacother 2014 Jul 3. Published online before print.
  • Denetclaw TH, Young EW, Tiemeier AM, Scott JD, Hartzler ML. Perceptions, obstacles, and solutions for offering introductory pharmacy practice experiences in the community hospital setting: a qualitative survey. Curr Pharm Teach Learn 2014;6:632-8.
• Alexander H. Flannery, Pharm.D., BCPS
  • Flannery AH, Flynn JD. More questions than answers in ICU delirium: pressing issues for future research. Ann Pharmacother 2013;47:1558-61.
  • Flannery AH, Hatton KW, Phillips B. Sedation and delirium [letter]. N Engl J Med 2014;370:1566-7.
  • Flannery AH, Thompson-Bastin M. Oseltamivir dosing in critically ill patients with severe influenza. Ann Pharmacother 2014;48:1011-8.
  • Flynn JD, McConeghy KW, Flannery AH, et al. Utilization of pharmacist responders as a component of a multidisciplinary sepsis bundle. Ann Pharmacother 2014;48:1145-51.
• Lori Hornsby, Pharm.D., BCPS; Haley M. Phillippe, Pharm.D., BCPS; and Sarah Treadway, Pharm.D., BCPS
  • Armstrong EM, Bellone J, Hornsby LB, Treadway S, Phillippe HM. Acquired thrombophilia. J Pharm Pract 2014;27:234-42.
  • Armstrong EM, Bellone J, Hornsby LB, Treadway S, Phillippe HM. Pregnancy-related venous thromboembolism. J Pharm Pract 2014;27:243-52.
  • Hornsby LB, Phillippe HM, Treadway S, Armstrong EM, Bellone J. Thrombophilia screening. J Pharm Pract 2014;27:253-9.
  • Phillippe HM, Hornsby LB, Treadway S, Armstrong EM, Bellone J. Inherited thrombophilia. J Pharm Pract 2014;27:227-33.
• Lamis R. Karaoui, Pharm.D., BCPS
  • Rafie S, McIntosh J, Shealy KM, Borgelt LM, Forinash A, Shrader SP, Koepf ER, McClendon KS, Griffin BL, Horlen C, Karaoui LR, Rowe EL, Lodise NM, Wigle PR. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2014 Jul 3. [Epub ahead of print]
• Katie S. McClendon, Pharm.D., BCPS
  • McClendon KS, Malinowski SS, Pitcock JJ, Brown MA, Davis CS, Sherman JJ, Riche DM, Bloodworth LS, Warrington LE. A multipreceptor approach to ambulatory care topic discussions. Am J Pharm Educ 2014;78:77.
  • McClendon KS, Stover KR. Tips for a successful poster presentation. Am J Health Syst Pharm 2014;71:449-51.
  • Rafie S, McIntosh J, Shealy KM, Borgelt LM, Forinash A, Shrader SP, Koepf ER, McClendon KS, Griffin BL, Horlen C, Karaoui LR, Rowe EL, Lodise NM, Wigle PR. Pharmacist roles in long-acting reversible contraception use: an opinion of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2014 Jul 3. [Epub ahead of print]
  • Wright EA, Brown B, Gettig J, Martello JL, McClendon KS, Smith KM, Teeter J, Ulbrich TR, Wegrzyn N, Bradley-Baker LR. Teaching and learning curriculum programs: recommendations for postgraduate pharmacy experiences in education. Am J Health Syst Pharm 2014;71:1292-302.
• Sarah A. Nisly, Pharm.D., BCPS
  • Dy EA, Nisly SA. Evaluation and revision of an introduction to experiential rotations course. J Scholarship Teach Learn 2014;14:34-45.
  • Nisly SA, Isaacs A, Merkel KG. Use of Web-based learning modules for a general medicine advanced pharmacy practice experience. Curr Pharm Teach Learn 2014;6:502-6.
• Michael J. Peeters, Pharm.D., MEd, BCPS
  • King PK, Szczerba FM, Rega PP, Peeters MJ. Interprofessional education and simulation: are we hitting the mark? Curr Pharm Teach Learn 2014;6:588-91.
  • Peeters MJ, Schmude KA, Steinmiller CL. Inter-rater reliability and false confidence in precision: using standard error of measurement within PharmD admissions essays rubric development. Curr Pharm Teach Learn 2014;6:298-303.
• Heather Whitley, Pharm.D., BCPS, CDE
  • Lee R, Whitley HP. Social media use to support diabetes mellitus care: the development of Countryside Diabetes. Consult Pharm 2014;29:53-7.

Presentations:

• Michael J. Peeters, Pharm.D., MEd, BCPS, presented a special session at the AACP Annual Meeting in July, “Building Reliable Assessments: OSCEs, Multiple Mini-interviews & Performance Assessments.”
• Beth H. Resman-Targoff, Pharm.D., FCCP, presented “Individualizing Rheumatoid Arthritis Therapy” at the American Pharmacists Association Annual Meeting and Exposition in Orlando, Florida, in March 2014. Her session was one of 11 sessions selected for videotaping and use as a home-study offering.

New ACCP Fellows:

We would like to congratulate the following EDTR PRN members selected as ACCP Fellows for 2014.

• Sandra Benavides, Pharm.D. (Nova Southeastern University)
• P. Brandon Bookstaver, Pharm.D., BCPS (AQ-ID) (University of South Carolina)
• Allison M. Chung, Pharm.D., BCPS, AE-C (Auburn University Harrison School of Pharmacy, Mobile Campus)
• Craig D. Cox, Pharm.D., BCPS (Texas Tech University)
• Samantha A. Karr, Pharm.D., BCPS, BCACP (Midwestern University)
• Joel C. Marrs, Pharm.D., BCPS, CLS (University of Colorado - Denver)
• Michael J. Peeters, Pharm.D., MEd, BCPS (University of Toledo College of Pharmacy & Pharmaceutical Sciences
• Mary E. Temple Cooper, Pharm.D., M.S., BCPS (Hillcrest Hospital, Chagrin Falls, OH)

Other Notable Achievements:

• Miranda Andrus, Pharm.D., FCCP, BCPS, was the faculty mentor for Jeanne Forrester, Pharm.D., recipient of the AACP Walmart Scholars Program Award in July 2014.
• Samantha A. Karr, Pharm.D., BCPS, BCACP, was elected vice chair of the BPS Specialty Council on Ambulatory Care Pharmacy for 2015.
• Kristi Kelley, Pharm.D., FCCP, BCPS, CDE, received her certification as a Board Certified Advanced Diabetes Manager (BC-ADM) in July 2014.

CURRENT OFFICERS

• Chair: Mary Beth Shirk, Pharm.D., FCCP, BCPS
• Chair-Elect: Kyle Weant, Pharm.D., BCPS
• Immediate Past Chair: Nicole M. Acquisto, Pharm.D., BCPS
• Secretary/Treasurer: Darrel Hughes, Pharm.D., BCPS

COMMITTEE UPDATES

Programming Committee

On Monday, October 13, from 3:45 to 5:45 p.m., don’t miss afternoon programming developed by members of the Emergency Medicine PRN, which will focus on treating illicit drug intoxications in the emergency department, identifying potential treatment strategies for approaching toxidromes consistent with illicit drug intoxication, developing a treatment plan for an undifferentiated patient with a potential illicit drug intoxication, and discussing specific treatment strategies. Presenters will also provide a review of wilderness bites and envenomations; identify potential treatment strategies; discuss design dispensing, administration, and treatment protocols for common wilderness medicine presentations; and review opportunities to optimize care for those who are admitted to various inpatient services. The session will also include a review of prehospital care for illicit drug intoxication and wilderness bites. Those who have questions can contact Kyle Weant by e-mail ([email protected]).

Justification Task Force

The Justification Task Force continues its mission to provide a framework for developing an optimal business and practice model for the emergency department. The task force has finished developing an outline and detailed structure for the final recommendations and is now moving to the writing stages. Using an extensive database of primary literature to support recommendations, we anticipate that an initial draft of this framework will be completed by the end of the year. Those who have questions can contact Kyle Weant by e-mail ([email protected]).

Travel Award

The Travel Award Committee will award a Student and Resident Research Travel Award this year to help support the costs of travel and attendance at the 2014 ACCP Annual Meeting. A call for abstracts went out in August, e-mailed to members of the EMED PRN, and the deadline was September 1, 2014. Award winners will be notified by Monday, September 15, and they will present their research at the Emergency Medicine PRN business meeting and networking forum on Tuesday, October 14, at the 2014 ACCP Annual Meeting in Austin, Texas. For more information regarding the Travel Awards, please visit the EMED PRN Web site (www.accp.com/docs/prns/emed/Travel_Award_-_EMED_PRN.pdf) or e-mail Nicole Acquisto ([email protected]).

Awards and Recognition Committee

The committee is currently developing PRN-specific awards to highlight members of the EMED PRN. The goal is to have these awards established and our first awardees designated by the 2015 Annual Meeting. In addition, the committee has supported nominations for the member spotlight for two cycles and is currently receiving nominations for student members. To date, the following individuals have been submitted for member spotlight:

• Member: Mason Bucklin, Pharm.D.
• Resident/Fellow: Elizabeth Giesler, Pharm.D., BCPS

Those who are interested in joining this committee or who have questions can contact Megan Musselman by e-mail ([email protected]).

Student Task Force

The Student Committee Task Force has finalized a survey that will be sent to all student members of the ACCP EMED PRN near the beginning of the academic school year (late August/early September). The purpose of this survey is to gather information regarding current student involvement in ACCP and the EMED PRN, available experiences in emergency medicine pharmacy and research, and interest in opportunities set forth by the EMED PRN Student Committee. Compiled data from the survey and the finalized Student Committee Framework and Responsibilities document will be presented at the EMED PRN business and networking forum on Tuesday, October 14, at the 2014 ACCP Annual Meeting in Austin, Texas.

The EMED PRN would like to acknowledge and congratulate all of its members on their accomplishments and achievements, especially those listed in the following sections.

AWARDS

• Kyle Strnad was named Thomas Jefferson University School of Pharmacy’s “Mr. Pharmacy” at the first annual school-run talent show.

ASHP Pharmacy Practice Research Award – 2013

• Asad E. Patanwala, Pharm.D., Arthur B. Sanders, M.D., MHA, Michael C. Thomas, Pharm.D., Nicole M. Acquisto, Pharm.D., Kyle A. Weant, Pharm.D., Stephanie N. Baker, Pharm.D., Erica M. Merritt, Pharm.D., and Brian L. Erstad, Pharm.D., for their publication: A prospective, multicenter study of pharmacist activities resulting in medication error interception in the emergency department. Ann Emerg Med 2012;59:369-73.

ASHP Foundation Pharmacy Resident Practice-Based Research Grant

• C.B. Adams, K.E. Vollman, and N.M. Acquisto for their project titled “Survey of Emergency Medicine Pharmacy Education Opportunities for Students and Residents” ($5000)

AI/UK Teamwork Award for Nursing Support

• Abby Bailey, Regan Baum, and Stephanie Baker Justice

University of Florida College of Pharmacy’s Outstanding Young Alumni of the Year

• Katelyn Dervay

Critical Care Pharmacotherapy Trials Network Research Proposal Acceptance

• C. Groth and N.M. Acquisto, co-PI, for their project titled “Current Practices and Safety of Medication Use During Rapid Sequence Intubation

PRESENTATIONS

• Awad NI, Brunetti L. Recommendations from North American Poison Control Centers on strategies for reversal of life-threatening bleeding secondary to target specific oral anticoagulants. Accepted for poster presentation at: Annual Meeting of the North American Congress of Clinical Toxicology; October 2014; New Orleans, LA.
• Awad NI. Reversal strategies of anticoagulation therapies. Anticoagulation and Stroke Care Panel Presentation. Presented at: New Jersey State Stroke Conference, Northeast Cerebrovascular Consortium; April 2014; New Brunswick, NJ.
• Musselman M, Awad NI, Coralic Z. Emerging in the ED: primer for starting in the emergency department. Live Webinar Presentation. Section Advisory Group on Emergency Care. Section of Clinical Specialists and Scientists. Presented at: American Society of Health-System Pharmacists; May 2014.
• Strnad K. Pharmacist approach to common medication overdoses in the ED. ACPE Continuing Education Presentation. Presented as part of the session “Hot Topics in Patient Safety/Annual Night with Industry” at: Delaware Valley Society of Health-System Pharmacists Meeting; April 15, 2014; Philadelphia, PA.
• Thomas MC. ACCP Ambulatory Care Prep Course faculty (Health Maintenance/Public Health)

PROMOTIONS

• Nicole M. Acquisto, Pharm.D., BCPS – Promoted to a level 3 clinical pharmacy specialist – University of Rochester Medical Center, Department of Pharmacy
• Abby Bailey: Named PGY2 Emergency Medicine Residency Program director
• Abby Bailey: Non-physician faculty member, Department of Emergency Medicine, University of Kentucky College of Medicine
• Kyle Strnad: Chair, National Student Network Advisory Committee (July 2014)
• Michael Thomas: Vice chair and clinical associate professor (Western New England University)
• Kyle Weant: Clinical pharmacy services manager, KentuckyOne Health

PUBLICATIONS

• Acquisto NM. Heparin. In: Wexler P, ed. Encyclopedia of Toxicology, 3rd ed., vol 2. New York: Elsevier, 2014:837-9.
• Acquisto NM. 2014. Isoniazid. In: Wexler P, ed. Encyclopedia of Toxicology, 3rd ed., vol 2. New York: Elsevier, 2014:1135-7.
• Awad NI, Bridgeman MB. Continuing education program planning: tips for assessing staff educational needs. Am J Health Syst Pharm 2014. In press.
• Awad NI, Cocchio C. An analysis of the use of Twitter at a major national pharmacy conference. Am J Health Syst Pharm 2014. In press.
• Awad NI, Cocchio C. Active prothrombin complex concentrates (aPCCs) for the reversal of anticoagulant-associated coagulopathy. P T 2013;38:696-701.
• Bailey AM, Baker SN, Baum R, Chandler H, Weant KA. Being prepared: emergency treatment following nerve agent release. Adv Emerg Nurs J 2014;36:22-33.
• Bailey AM, Baker SN, Weant KA. Tranexamic acid for trauma-related hemorrhage. Adv Emerg Nurs J 2014;36:123-31.
• Bailey AM, Wermeling DP. Naloxone for opioid overdose prevention: pharmacists’ role in community-based practice settings. Ann Pharmacother 2014 Feb. [Epub ahead of print]
• Bodkin RB, Acquisto NM. Medical treatment during pregnancy. Harwood-Nuss’ Clinical Practice of Emergency Medicine, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2014:699-705.
• Bodkin RB, Acquisto NM. Rapid sequence intubation. In: Encyclopedia of Trauma Care. Heidelberg, Germany: Springer. Accepted for publication 2013.
• Bodkin RP, Acquisto NM, Zwart JM, Toussaint S. Differences in noninvasive thermometer measurements in the adult ED. Am J Emerg Med 2014; http://dx.doi.org/10.1016/j.ajem.2014.05.036.
• Bucklin MH, Acquisto NM, Nelson C. The effects of recombinant activated factor VII dose on the incidence of thromboembolic events in patients with coagulopathic bleeding. Thromb Res 2014;133:768-71.
• Bucklin MH, Gorodetsky RM, Wiegand TJ. Prolonged lipemia and pancreatitis due to extended infusion of lipid emulsion in bupropion overdose. Clin Toxicol 2013;51:896-8.
• Bucklin MH, Groth CM. Mortality following rasburicase-induced methemoglobinemia. Ann Pharmacother 2013;47:1353-8.
• Cocchio C, Awad NI. The scholarly merit of social media use among clinical faculty. J Pharm Technol 2014;30:61-8.
• Dark M. Emergency department toxicology: diphenhydramine overdose in a male adult. Pharm Pract 2014;41:20-1.
• Engle JP, Erstad BL, Anderson DC, Bucklin MH, Chan A, Donaldson AR, Hagemann TM, Rodgers PT, Schwinghammer T, Tennant S, Thomas Z. Minimum qualifications for clinical pharmacy practice faculty. Pharmacotherapy 2014;34:e38-e44.
• Fosmire E, Strnad K. Life of an ED intern—what are the expectations? ACCP Emergency Medicine PRN Newsletter, April 2014.
• Groth C, Acquisto NM. Histamine-1 blockers. In: Wexler P, ed. Encyclopedia of Toxicology, 3rd ed., vol 1. New York: Elsevier, 2014:809-12.
• Groth CM, Acquisto NM. Pharmacists as members of the rapid response team. J Pharm Pract 2014. Accepted for publication.
• Gubbins PO, Micek ST, Badowski M, Chen J, Gallagher J, Johnson SG, Karnes JH, Lyons K, Moore KG, Strnad K. Innovation in clinical pharmacy practice and opportunities for academic-practice partnership. Pharmacotherapy 2014;34:e45-e54.
• Harbison AF, Polly D, Musselman ME. Safe and effective use of anti-infectives in pregnancy and lactation in the emergency department. Am J Health Syst Pharm. In press.
• Musselman ME, Hampton JP. “Not for human consumption”: a review of emerging designer drugs. Pharmacotherapy 2014.
• Nobay F, Acquisto NM. Barbiturates. In: Wexler P, ed. Encyclopedia of Toxicology, 3rd ed., vol 1. New York: Elsevier, 2014:363-7.
• Philips MA, Acquisto NM, Gordetsky RM, Wiegand TJ. Use of a physostigmine infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose. J Med Toxicol 2014;10:205-9.
• Strnad K. Key qualities necessary for PGY1 residencies: a review of the 2012 Educational Affairs Committee position statement. ACCP StuNews, April 2014.
• Thomas MC. Health maintenance/public health I. In: Bainbridge JL, Clark N, Coyle EA, et al., eds. Updates in Therapeutics®: The Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2014. Lenexa, KS: American College of Clinical Pharmacy, 2014:2-643-2-673.
• Thomas MC, Ademolu AO. Considerations for vaccine administration in the emergency department. Am J Health Syst Pharm 2014;71:231-6.
• Thomas MC, Macias-Moriarity L. Student knowledge and confidence in an elective clinical toxicology course using active-learning techniques. Am J Pharm Educ 2014;78:Article 95.
• Thompson ML, Baker SN, Weant KA. Effects of etomidate on adrenal suppression: a review of intubated septic patients. Hosp Pharm 2014;49:177-83.
• Vollman KE, Acquisto NM, Bodkin RP. A case of tetanus infection in an adult with a protective tetanus antibody level. Am J Emerg Med 2013, http://dx.doi.org/10.1016/j.ajem.2013.10.025.
• Vollman KE, Acquisto NM, Bodkin RP. Response to “Protective effect of tetanus antibodies.” Am J Emerg Med 2014. http://dx.doi.org/10.1016/j.ajem.2014.05.049.
• Vollman KE, Acquisto NM, Bodkin RP. Response to “Considerations for tetanus infection in an adult with a protective antibody level.” Am J Emerg Med 2014. http://dx.doi.org/10.1016/j.ajem.2014.06.009.
• Weant KA, Bailey AM, Baker SN. Strategies for reducing medication errors in the emergency department. J Open Access Emerg Med 2014;6:45-55.
• Weant KA, Bailey AM, Baker SN. Hyperglycemia in critical illness. Adv Emerg Nurs J 2013;35:209-16.
• Weant KA, Bailey AM, Fleishaker EL, Baker SN. Being prepared: bioterrorism and mass prophylaxis: part I. Adv Emerg Nurs J 2014;36:226-38.

The Endocrine and Metabolism PRN consists members from a variety of practice settings. The PRN was formed to achieve the following goals and objectives. (1) Provide an opportunity for pharmacists with an interest in endocrine and metabolism disorders to promote practice, research, and education in these areas. (2) Provide a mechanism for members with similar interests to meet during ACCP meetings to network, problem-solve, and discuss professional issues and opportunities. (3) Promote practice involvement; educational needs of health care professionals, students, and patients; and research activities in the areas of endocrinology and metabolism that may be favorably affected by this ACCP PRN effort.

During the past 6 months, some notable member accomplishments are as follows.

Appointments and Promotions

• Mandy Reece
  • Promoted to vice chair, Department of Pharmacy Practice, Philadelphia College of Osteopathic Medicine – Georgia Campus

Awards/Grants

• Miranda Andrus with Jeanne Forrester, Pharm.D. Candidate: Student/faculty recipient for the 2014 AACP Walmart Scholars Program
• Brian Irons: Coinvestigator, HRSA grant titled “Nurse Education, Practice, Quality and Retention – Interprofessional Collaborative Practice”
• Nicole Pinelli: Coinvestigator, Centers for Medicare & Medicaid Services Health Care Innovation Award Grant: “Optimizing the Medical Neighborhood: Transforming Care Coordination Through the North Carolina Community Pharmacy Enhanced Services Network”
• Angela Skaff
• Recipient, ASHP Student Leadership Award
• Recipient, Cardinal Health Scholarship
• Recipient, FSHP Paul Magalian Student Leadership Award
• Barakha Yadav: ACCP Endocrine and Metabolism Resident Travel Scholarship
• Kimberly Zitko: ACCP Endocrine and Metabolism Student Travel Scholarship

Publications

• Lisa Chastain and Megan Kildow: Chastain LM, Stapleton M, Frost J. A comparison of US treatment guidelines for type 2 diabetes mellitus: applications to the newly diagnosed patient. Diabetes Manage 2014;4:273-83.
• Mandy Reece
• Reece SW, Williams C. Insulin pump class: back to the basics of pump therapy. Diabetes Spectrum 2014;27:135-40.
• Reece SW, Kanopka A, Mervin I. Use of rapid-acting insulin analogs during pregnancy. Pract Diabetol 2014;33:12-4.
• Heather Whitley: Lee R, Whitley HP. Social media use to support diabetes mellitus care: the development of Countryside Diabetes. Consult Pharm 2014;29:53-7.

Presentations

• Nicole R. Pinelli: McLaughlin J, Poppe LB, Chen S, Luter D, Arnall J, Smith S, Roth M, Rodgers P, Williams D, Pinelli NR. Improved organizational outcomes and enhanced student learning in an early immersion program at an academic medical center. Presented at: 2014 AACP Annual Meeting; July 2014.
• Heather Whitley: Yong EV, Whitley HP. 12-month impact of Countryside Diabetes, a social media diabetes educational tool, by quantifying membership response rates to post type and topic for enhancing future care of disease management. Poster presented at: 2014 Virtual Poster Symposium, American College of Clinical Pharmacy; May 2014.

New ACCP Fellows

• Samantha A. Karr, Pharm.D., BCPS, BCACP, BC-ADM; Midwestern University, Glendale, Arizona
• Joel C. Marrs, Pharm.D., BCPS (AQ Cardiology), BCACP, CLS; Skaggs School of Pharmacy
• Alissa R. Segal, Pharm.D.; Massachusetts College of Pharmacy and Health Sciences Newton, Massachusetts

Other Notable Achievements

• Samantha Karr was elected as vice chair for the 2015 BPS Ambulatory Care Council.
• Heather Whitley will be accepting a clinical pharmacy specialist position at Baptist Health, Montgomery Family Medicine Residency Program, in Montgomery, Alabama, and retain employment with Auburn University.
• The Endocrine and Metabolism PRN has more than 250 members and represents a diverse group of clinical pharmacists and students dedicated to advancing clinical practice, teaching, and research. The Endocrine and Metabolism PRN would like to welcome the newest members of the group:
  • Saffia Abu-Shendi
  • Sneha Baxi
  • Vincent Brett
  • Mark Britton
  • Robin Carney
  • Megan Carr
  • Christa Curtis
  • Laruen Fox
  • Joseph Fulginiti
  • Jessica George
  • Nicholas Giruzzi
  • Megan Jensen
  • Yi Liu
  • Rashida Lloyd
  • James Lokken
  • Anna Marsakova
  • Richard Molinaro
  • Cody Moore
  • Imelda Palit
  • Leslie Richard
  • Heather Shull
  • Sarah Smith
  • Bradly Winter

Monthly Online Journal Club

The Communication Committee continues to lead the PRN in the monthly online journal club on our PRN e-mail list. The online journal club was implemented in February 2010. The purpose of the online journal club is to provide an awareness of key articles that add new information to the fields of endocrinology and metabolism. Members of the PRN are periodically asked to contribute articles and comments to foster active discussion. Active members from the Communication Committee have been soliciting journal club articles from the PRN e-mail list and have been posting one or two articles every month. The following members have been involved in continuing the monthly online journal club: Lisa Chastain (Communication Committee chair), Ben Gross (member), Richard Hess (member), Robin Koffarnus (member), Molly Minze (member), Sara “Mandy” Reece (member), Christie Schumacher (member), and Linda Thomas (member). Please contact Lisa Chastain, [email protected], for more information about the online journal club.

Introduction:

Please join us at the 2014 ACCP Annual Meeting in Austin, Texas, from October 12 to 15. During the meeting on Tuesday, October 14, three members of the GILN PRN—Rima Mohammad, Pharm.D., BCPS; Bryan Love, Pharm.D., BCPS; and Paulina Deming, Pharm.D., PhC—will be presenting a focus session titled “Updates in Pharmacotherapeutic Management of Hepatitis C Virus Infection” from 10:15 a.m. to 12:15 p.m.

The GILN PRN will also be hosting our annual business meeting on Tuesday, October 14, from 6 to 9 p.m., which will be open to current and prospective members. Appetizers and beverages will be provided.

Publications:

• 1. Frazee E, Nystrom EM, McMahon MM, Miles JM. Relationship between triglyceride tolerance, body mass index, and fat depots in hospitalized patients receiving parenteral nutrition. JPEN J Parenter Enteral Nutr 2014 Jun 11. [Epub ahead of print]
• Martin MT. New product review: Sovaldi (sofosbuvir). Ill Pharm 2014;76:30-2.
• Martin MT, Aloman C, Stewart CA. To treat or not to treat: weighing the options with current hepatitis C treatment. Specialty Pharma J 2014(Hepatitis C Edition):21-3.
• Martin MT, Hanson RL. Paving pathways for hepatitis C treatment: pharmacists’ strategies for removing obstacles in pursuit of achieving sustained virological response. Specialty Pharma J 2014(Hepatitis C Edition):11-3.
• Mills BL, Martin MT. Drug interactions in hepatitis C and HIV treatment: pharmacists’ tips for selecting appropriate agents that play well with the patient’s HIV regimen. Specialty Pharma J 2014(Hepatitis C Edition):17-20.
• Mohammad RA, Smith MA. Advances in biologic therapies for gastrointestinal diseases. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2014 Book 2. Chronic Illnesses. Lenexa, KS: American College of Clinical Pharmacy, 2014:261-89.
• Smith MA, Johnson HJ, Chopra K, Dunn M, Ulrich A, Mohammad RA. Incidence and management of rash in telaprevir-treated patients: lessons for simeprevir? Ann Pharmacother 2014;48:1166-71.
• Smith MA, Mohammad RA, Benedict NJ. Use of virtual patients in an advanced therapeutics pharmacy course to promote active, patient-centered learning. Am J Pharm Educ 2014;78:Article 125.

New ACCP Fellows:

• Julie M. Sease, Pharm.D., BCPS, CDE; and Sheila M. Wilhelm, Pharm.D., BCPS, became Fellows of ACCP this year.

Other Notable Achievements:

• Michelle Martin, Pharm.D., BCPS, BCACP, had several noteworthy presentations, including “Managing Viral Hepatitis in Primary Health Care Settings and Exploring the Role of Non-physician Clinicians” at the 4th International Conference on Viral Hepatitis (March 2014; New York, NY); and “Going Viral! Hepatitis C Treatment in the Age of Direct-Acting Antivirals” at the Annual Meeting for the Illinois Council on Health-System Pharmacists (September 2014; Oakbrook Terrace, IL).
• April Smith, Pharm.D., BCPS, was invited by the American Society for Metabolic and Bariatric Surgery to serve as a course director for a special session at their annual meeting in Boston on November 3 focusing on pharmacology issues in bariatric surgery patients. For this session, Dr. Smith gathered pharmacists from around the country to present on different topics and highlight our utility and expertise for this patient population.

Publications:

• Benedict N, Felbinger M, Anthes A, Altawalbeh S, Ridenour TA, Kane-Gill S. Correlation of patient reported outcomes of sedation and sedation assessment scores in critically ill patients. J Crit Care 2014. [Epub ahead of print]
• Debenito JM, Billups SJ, Tran TS, Price LC. Impact of a clinical pharmacy anemia management service on adherence to monitoring guidelines, clinical outcomes, and medication utilization. J Manag Care Pharm 2014;20:715-20.
• Kane-Gill SL, Leblanc JL, Dasta JF, Devabhakthuni S; for the Critical Care Pharmacotherapy Trials Network. A multicenter study of the point prevalence of drug-induced hypotension in the ICU. Crit Care Med 2014. [Epub ahead of print]
• Kloet MA, Lohr BR, Smithburger PL, Seybert AL, Kane-Gill SL. Assessment of inpatient boxed warning adherence. J Patient Saf 2014. [Epub ahead of print]

Awards:

• Sarah J. Billups, Pharm.D., BCPS, was awarded the Performance Improvement Triple Aim (PITA) Award for her project: “A Research-Based Approach to the Care of Our Patients with Osteoporosis.”
• From Sandra Kane-Gill, Pharm.D., M.Sc., FCCP, FCCM

Introduction:

The Hematology/Oncology PRN has been very active in the past year, continuing its work to provide a forum for hematology/oncology pharmacists to network and collaborate in research and clinical practice. We are looking forward to our Hem/Onc PRN focus session in October at the 2014 ACCP Annual Meeting, which will present innovative practice models within hematology/oncology pharmacy practice and highlight collaborative practice agreements, MTM programs, and ways to include students and residents in the practice environment. The Hem/Onc PRN Paper Committee continues to work on developing a survey method for gathering data for use in a publication that will evaluate current types of clinical practices of hematology/oncology pharmacists in our PRN. The PRN Student/Resident Award Committee was successful in developing criteria for the Resident of the Year Award as well as for the travel awards for students and residents. The Hem/Onc PRN is also excited to support David DeRemer with a full-tuition 2014 FIT scholarship.

Promotions:

• Ryan Bookout, Pharm.D., BCOP, BCPS, was promoted to oncology pharmacy residency program director at Moffitt Cancer Center.
• Niesha Griffith, R.Ph., M.S., FASHP, was promoted to administrator of oncology pharmacy and infusion services at James Cancer Hospital and Solove Research Institute at The Ohio State University.
• Christy Harris, Pharm.D., BCPS, BCOP, was promoted to associate professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences University.
• Jeannine McCune, Pharm.D., BCOP, was promoted to full member at the Fred Hutchinson Cancer Research Center, effective July 1, 2014, and was appointed as an adjunct professor in the University of Washington Department of Pharmaceutics, effective March 1, 2014.
• Kellie Jones Weddle, Pharm.D., FCCP, BCOP, was promoted to clinical professor at Purdue University College of Pharmacy.

Awards:

• Lucas Okumura, R.Ph.: 6th Clinical Medical Award; best oral presentation at VI Clinical Medical Journey

Grants:

• Niesha Griffith, R.Ph., M.S., FASHP, received an ASHP Pharmacy Residency Expansion Grant for the PGY2 Oncology Pharmacy Residency Program at the James Cancer Hospital at The Ohio State University. The grant was awarded to assist in expanding the program to allow for a third PGY2 resident as the department moves into the new cancer tower.
• Lisa Holle, Pharm.D., BCOP, received UCHC-UConn Storrs seed grant funding in cancer control in June 2014 for the Pharmacist Intervention in Colorectal Cancer Screening Initiative (PICCSI).
• Jeannine S. McCune, Pharm.D., BCOP, successfully obtained a new R01 titled “Optimizing Busulfan: Efficacy, Toxicity, and Pharmacometabolomics,” which seeks to improve overall survival in hematopoietic stem cell transplant recipients by personalizing their conditioning regimen and/or intravenous busulfan doses using metabolomics. This work, done at the University of Washington, the Fred Hutchinson Cancer Research Center, and Seattle Children’s, is supported by a $2.4 million 5-year grant awarded by NCI (National Cancer Institute).

Publications:

• Ryan Bookout, Pharm.D., BCPS, BCOP
  • Parmar SR, Bookout R, Shapiro JF, Tombleson R, Perkins J, et al. Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma. Bone Marrow Transplant 2014;49:761-6.
• Christy Harris, Pharm.D., BCPS, BCOP
  • Szabatura AH, Cirrone F, Harris CS, McDonnell AM, Feng, Y, Voit D, Neuberg D, Butrynski J, Fisher DC. An assessment of risk factors associated with ifosfamide-induced encephalopathy in a large academic cancer center. J Oncol Pharm Pract 2014 Mar 23. [Epub ahead of print]
• Lisa Holle, Pharm.D., BCOP
  • Holle LM, Michaud LB. Oncology pharmacists in health care delivery: vital members of the cancer care team. J Oncol Pract 2014;10:e142-e145.
• Tali M. Johnson, Pharm.D., BCOP
  • Johnson TM. Multiple myeloma treatment and management in the elderly. Consult Pharm 2014;29:434-49.
• Jeannine McCune, Pharm.D., BCOP
  • Bemer MJ, Risler LJ, Phillips BR, Wang J, Storer BE, Sandmaier BM, Duan H, Raccor BS, Boeckh MJ, McCune JS. Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant 2014 Jun 9. [Epub ahead of print]
  • Diestelhorst C, Boos J, McCune JS, Hempel G. Population pharmacokinetics of intravenous busulfan in children: revised body weight-dependent NONMEM® model to optimize dosing. Eur J Clin Pharmacol 2014;70:839-47.
  • Diestelhorst C, Boos J, McCune JS, Russell J, Kangarloo SB, Hempel G. Predictive performance of a physiologically based pharmacokinetic model of busulfan in children. Pediatr Hematol Oncol 2014 Jul 9. [Epub ahead of print]
  • Li H, Mager DE, Sandmaier BM, Storer BE, Boeckh MJ, Bemer MJ, Phillips BR, Risler LJ, McCune JS. Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil. Biol Blood Marrow Transplant 2014;20:1121-9.
  • McCune JS, Bemer MJ, Barrett JS, Scott Baker K, Gamis AS, Holford NH. Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization. Clin Cancer Res 2014;20:754-63.
• Lucas Okumura, R.Ph.
  • Okumura LM, Rotta I, Correr CJ. Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review. Int J Clin Pharm. [Epub ahead of print]
• Jai N. Patel, Pharm.D.
  • Dressler LG, Deal AM, Patel JN, Markey J, Van Riper M, McLeod HL. Cancer pharmacogenomics, adoption by oncologists and patient benefit. Pers Med 2014;11:143-53.
  • Patel JN, McLeod HL. Pharmacogenomics and cancer therapy: somatic and germ-line Polymorphisms. In: Figg WD, McLeod HL, eds. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, 2nd ed. Totowa, NJ: Humana Press, 2014:255-72.
  • Patel JN, O’Neil BH, Deal AM, et al. A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil (5-FU) dosing for personalized colorectal cancer therapy. Oncologist 2014. Accepted for publication.
• Christine Walko, Pharm.D., BCOP
  • Walko CM, McLeod HL. Personalizing medicine in geriatric oncology. J Clin Oncol 2014. [Epub ahead of print]

New ACCP Fellows:

• Jeannine S. McCune, Pharm.D., BCOP
• Christine Walko, Pharm.D., BCOP

Other Notable Achievements:

• Ryan Bookout, Pharm.D., BCPS, BCOP, was elected Board Member-at-Large of HOPA for 2014–2016.
• Niesha Griffith, R.Ph., M.S., FASHP, announced her anticipated move in December 2014 into the new James Cancer Hospital and Solove Research Institute, a 420-bed, 21-story tower that integrates spaces for dedicated research, education, and patient care on each unit. Included in this expansion project is the first integrated oncology-specific emergency department in the country as well as oncology-specific critical care beds.
• Jeannine McCune, Pharm.D., BCOP, was appointed an associate editor for Clinical Pharmacology and Therapeutics.

Introduction: The Immunology/Transplantation Practice and Research Network (PRN) has grown to almost 450 members! We encourage all members to get involved and be sure to provide us with suggestions and comments to make our PRN even better.

Our PRN was well represented at World Transplant Congress 2014 with 61 posters and 25 oral presentations involving PRN members. Congratulations!

We would also like to take this opportunity to introduce our newly elected PRN officers for the upcoming 2014–2015 year:

• Chair: Reed Hall
• Chair-Elect: Christopher Ensor
• Secretary/Treasurer: Christina Doligalski

Please congratulate these new officers when you see them at the upcoming ACCP Annual Meeting.

Awards:

• Rita R. Alloway: 2014 ACCP Russell R. Miller Award
• Rosemary P. Cross: Atlanta Academy of Institutional Pharmacy (AAIP) Pharmacist of the Year award in May 2014
• Ninh (Irene) La-Beck: European Foundation for Clinical Nanomedicine Fellowship; 2014 Immunology/Transplantation PRN scholarship, ACCP Research Institute Focused Investigator Training (FIT) Program; 2014 ACCP FIT Certificate recipient
• First Place Poster Award in Translational Nanomedicine, European Summit for Clinical Nanomedicine and Targeted Medicine, June 25, 2014, Basel, Switzerland. (Rajan R, Sabnani M, Rowland B, Mavinkurve V, Wood L, Gabizon A, La-Beck NM. Effects of pegylated liposomes on functionality of macrophages and lymphocytes in tumors. Abstract 98.)
• Demetra Tsapepas: 2014 Immunology/Transplantation PRN scholarship, ACCP Research Institute Focused Investigator Training (FIT) Program; 2014 ACCP FIT Certificate recipient

Publications: We would like congratulate the following PRN members on their publications during the past several months.

Journal Articles:

• Abu Jawdeh BG, Cuffy MC, Alloway RR, Shields AR, Woodle ES. Desensitization in kidney transplantation: review and future perspectives. Clin Transplant 2014;28:494-507.
• Alloway RR, Eckhoff DE, Washburn WK, Teperman LW. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients. Liver Transpl 2014;20:564-75.
• Beermann KJ, Ellis MJ, Sudan DL, Harris MT. Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients of mycophenolate and prednisone. Clin Transplant 2014 Apr 23. [Epub ahead of print]
• Bunnapradist S, Ciechanowski K, West-Thielke P, Mulgaonkar S, Rostaing L, Vasudev B, Budde K; MELT Investigators. Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. Am J Transplant 2013;13:760-9.
• Diaz FJ, Berg MJ, Krebill R, Welty T, Gidal BE, Alloway R, Privitera M. Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs. Clin Pharmacokinet 2013;52:1033-43.
• Doligalski CT, Benedict K, Cleveland AA, Park B, Degrade G, Pappas PG, Baddley JW, Zaas DW, Harris MT, Alexander BD. Epidemiology of invasive mold infections in lung transplant recipients. Am J Transplant 2014;14:1328-33.
• Doligalski CT, Liu E, Sammons C, Logan AT, Silverman D. Sublingual administration of tacrolimus: current trends and available evidence. Pharmacotherapy. Accepted for publication.
• Doligalski CT, Verbosky M, Alexander E, Kotis D, Powell M. Practice management training in the PGY1 residency year: best practices from two nationwide surveys. Hosp Pharm 2014;49:247-52.
• Ejaz NS, Alloway RR, Halleck F, Dürr M, Budde K, Woodle ES. Review of bortezomib treatment of antibody-mediated rejection in renal transplantation. Antioxid Redox Signal 2014 Apr 28. [Epub ahead of print]
• Ejaz NS, Shields AR, Alloway RR, Sadaka B, Girnita AL, Mogilishetty G, Cardi M, Woodle ES. Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients. Am J Transplant 2013;13:3142-54.
• Ejaz NS, Sadaka B, Shields AR, Cardi M, Wadih G, Witte D, Abu Jawdeh BG, Alloway RR, Woodle ES. A Banff component scoring–based histologic assessment of bortezomib-based antibody mediated rejection therapy. Submitted for publication.
• Gaber AO, Alloway RR, Bodziak K, Kaplan B, Bunnapradist S. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. Transplantation 2013;96:191-7.
• Karimi R, Doyle IC. Introduction to immunology. In: Karimi R, ed. Biomedical and Pharmaceutical Sciences with Patient Care Correlations. Burlington, MA: Jones & Bartlett, 2014. ISBN-13: 9781449621087
• Kim M, Martin ST, Townsend KR, Gabardi S. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options. Pharmacotherapy 2014;34:733-44.
• Krisl JC, Alloway RR, Shields AR, Cardi MA, Woodle ES Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept. Transplantation 2014;97:e30-2.
• Lopilato AC, Doligalski CT, Caldiera C. Incidence and risk factor analysis for alterations in hemostasis in mechanical circulatory support recipients. Artif Organs. Accepted for publication.
• Martin ST, Cardwell SM, Nailor MD, Gabardi S. Hepatitis B reactivation and rituximab: a new boxed warning and considerations for solid organ transplantation. Am J Transplant 2014;14:788-96.
• Sawinski D, Forde KA, Trofe-Clark J, Patel P, Olivera B, Goral S, Bloom RD. Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies. J Am Soc Nephrol Accepted for publication July 2014.
• Shaver CM, Castilho JL, Grogan EL, Miller GG, Dummer JS, Cohen DN, Gray JN, Lambright ES, Loyd JE, Robbins IM. Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement. Am J Transplant. Accepted for publication.
• Tanriover B, Mohan S, Radhakrishnan J, Nickolas TL, Stone P, Tsapepas DS, Crew RJ, Dube GK, Sandoval PR, Samstein S, Dogan E, Gaston RS, Cohen DJ, Ratner LE, Hardy MA. Addressing organ shortage: expanding the role of dual kidney transplantation. Am J Transplant 2014;14:404-15.
• Tsapepas D, Langone A, Chan L, Wiland A, McCague K, Chisholm-Burns M. A longitudinal assessment of adherence with immunosuppressive therapy following kidney transplantation from the Mycophenolic Acid Observational REnal Transplant (MORE) study. Ann Transplant 2014;19:174-81.
• Tsapepas DS, McKeen JT, Martin ST, Walker-McDermott JK, Yang A, Hirsch J, Mohan S, Tiwari R. Risk Evaluation Mitigation Strategy programs in solid organ transplantation: the promises of information technology. J Am Med Inform Assoc 2014. [Epub ahead of print]
• Tsapepas DS, Mohan S. Preformed donor specific antibodies and risk of antibody mediated rejection in repeat renal transplantation. Transplantation 2014. [Epub ahead of print]
• Tsapepas DS, Powell JT, Martin ST, McDermott J, Yang A, Jirsch J, Mohan S, Tiwari R. Risk Evaluation Mitigation Strategy programs in solid organ transplantation: the promises of information technology. J Am Med Inform Assoc 2014.
• Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube GK, Crew RJ, Ratner LE, Cohen DJ, Mohan S. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation. Transplantation 2014;97:642-7.
• Woodle ES, Sadaka B, Girnita A, Walsh RC, Shields AR, Ejaz NS, Alloway RR, Brailey P, Cardi M, Abu Jawdeh BG, Roy-Chaudhury P, Govil A, Mogilishetty G. Prospective iterative trial of proteasome inhibitor–based desensitization. Am J Transplant. Accepted for publication.

Book Chapters:

• Woodle ES, Alloway RR, Ejaz NS. Plasma cell biology: principles for therapeutic design. In: Cecka JM, Terasaki PI, eds. Clinical Transplant. Terasaki Foundation Laboratory, 277-83.
• Krisl JC, Alloway RR, Woodle ES. Off-label use of immunosuppressive agents in solid organ transplantation. In: Textbook of Organ Transplantation. Hoboken, NJ: Wiley-Blackwell, 2014:chap 101. ISBN: 978-1-118-87014-3.
• Rogers CC, Pilch NA (Weimert), Tichy EM, Smith LA, Alloway RA. Transplant pharmacy services. In: Textbook of Organ Transplantation. Hoboken, NJ: Wiley-Blackwell, 2014:chap 123. ISBN: 978-1-118-87014-3.

Other Notable Achievements:

• Ninh (Irene) La-Beck:
  • Invited speaker, European Summit for Clinical Nanomedicine and Targeted Medicine, June 25, 2014, Basel, Switzerland; Academic editor, Medicine (Wolters Kluwer Health)

Introduction: The Infectious Diseases PRN (ID PRN) continues to grow with more than 2000 members, including 648 trainees. The ID PRN membership has increased by more than 70% during a 5-year period. The ID PRN continues to support educational and research endeavors.

In August 2014, the ID PRN—together with the ACCP Critical Care PRN, the Society of Infectious Diseases Pharmacists (SIDP), and the Clinical and Laboratory Standards Institute (CLSI)—offered a live webinar, “The Role of Antimicrobial Testing and Reporting in Antibiotic Stewardship.” Also this year, the ID PRN provided a full-tuition scholarship to three of its members, Raymond Cha, Emi Minejima, and Kayla Stover, to attend the ACCP Focused Investigator Training (FIT) Program.

The following ID PRN members have been elected Fellows of ACCP and will be honored during the Annual Meeting in Austin, Texas. The ID PRN congratulates:

• P. Brandon Bookstaver, Pharm.D., BCPS (AQ-ID); Columbia, SC
• Mitchell S. Buckley, Pharm.D., FCCM, BCPS; Phoenix, AZ
• Renee-Claude Mercier, Pharm.D., BCPS; Albuquerque, NM
• Rocsanna Namdar, Pharm.D., BCPS; Denver, CO
• Mary E. Temple Cooper, Pharm.D., M.S., BCPS; Chagrin Falls, OH

Promotions:

• Samuel Aitken: Accepted a position as a clinical pharmacy specialist in infectious diseases at the University of Texas MD Anderson Cancer Center after completing a fellowship in infectious diseases at Baylor St. Luke’s Medical Center/University of Houston College of Pharmacy
• David Ha: Accepted a position as an assistant professor of clinical sciences (infectious diseases) at the Keck Graduate Institute School of Pharmacy after completing a PGY2 residency at the University of California, San Diego
• David Lourwood: Promoted to an adjunct clinical associate professor at the St. Louis College of Pharmacy and the University of Missouri-Kansas City

Awards:

• Emily Heil: University of Maryland Pharmacy Residency and Fellowship Programs Preceptor of the Year
• Paul Lata: 2014 Pharmacist of the Year for Wisconsin by the Pharmacy Society of Wisconsin
• Kady Phe: Society of Infectious Diseases Pharmacist (SIDP) 2013–2014 Infectious Diseases Pharmacotherapy Paper Award
• Angela Skaff: American Society of Health-System Pharmacists (ASHP) Student Leadership Award/Cardinal Health Student Scholarship/Florida Society of Health-System Pharmacists (FSHP) Paul Magalian Student Scholarship
• Velliyur Viswesh: California Northstate University College of Pharmacy/Class of 2015 – Teacher of the Year (therapeutics course coordinator - infectious disease)

Grants:

• Debra Goff: Received an Engagement Impact Grant from Ohio State’s Office of Outreach and Engagement to assist with her project, “Ohio State and South Africa Collaborate to Combat Antibiotic Resistant ‘Superbugs.’” Goff’s project was launched in 2013 with funding from the College of Pharmacy and South African hospital collaborators, connecting South African pharmacists with Ohio State mentors to develop the necessary skill set to contribute to antibiotic stewardship.
• Emily Heil: Patient Safety and Quality Improvement at the Point of Care. Interprofessional Education and Interprofessional Care Seed Grant. University of Maryland Center for Interprofessional Education
• Kady Phe: 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Infectious Diseases Fellows Grant Program
• Marc Scheetz: Received a grant from National Institute of Allergy and Infectious Diseases (NIAID) for “Elucidation of an Informed Drug Dosing Scheme to Minimize Kidney Injury”
• Kayla Stover: Received a grant from the pharmaceutical industry

Publications (limited to 3):

• Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother 2014;48:683-90.
• Aitken SL, Joseph TB, Shah DN, Lasco TM, Palmer HR, DuPont HL, Xie Y, Garey KW. Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. PLoS One 2014;9:e102848.
• Bland CM, Bookstaver PB, Lu ZK, Dunn BL, Rumley KF. Musculoskeletal safety outcomes of patients receiving daptomycin with HMG-CoA reductase inhibitors. Antimicrob Agents Chemother 2014 Jul 14 [Epub ahead of print]
• Bookstaver PB, Capino AC, Bookstaver NK. A pharmacy concierge service to optimize fidaxomicin therapy. Am J Health Syst Pharm 2014;71:986-7.
• Bookstaver PB, Justo JA. Commentary on “Incidence and predictors of vancomycin-associated nephrotoxicity.” South Med J 2014;107:389-90.
• Bosch K, McLaughlin MM, Esterly JS, Rhodes NJ, Postelnick MJ, Scheetz MH. Impact of vancomycin treatment duration and dose on kidney injury. Int J Antimicrob Agents 2014;43:297-8.
• Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA. The risk of seizures among the carbapenems: a meta-analysis. J Antimicrob Chemother 2014;69:2043-55.
• Darkoh C, Turnwald BP, Koo HL, Garey KW, Jiang ZD, Aitken SL, DuPont HL. Colonic immunopathogenesis of Clostridium difficile infections. Clin Vaccine Immunol 2014;21:509-17.
• Dilworth TJ, Leonard SN, Vilay AM, Mercier RC. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model. Clin Ther 2014 Jul 24. [Epub ahead of print]
• Goff DA, Bauer KA, Mangino JE. Bad bugs need old drugs: a stewardship program’s evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections Clin Infect Dis 2014.
• Goff DA, Kayes K. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2014.
• Kisgen J, Mansour H, Unger N, Childs LM. Tedizolid: a new oxazolidinone antimicrobial. Am J Health Syst Pharm 2014;71:621-33.
• Kular R, Goff DA. Transformation of antimicrobial stewardship programs through technology and informatics. Infect Dis Clin North Am 2014;28:291-300.
• Phe K, Johnson ML, Palmer HR, Tam VH. Validation of a model to predict the risk of nephrotoxicity in patients receiving colistin. Antimicrob Agents Chemother 2014 Aug 18. [Epub ahead of print]
• Phe K, Lee Y, McDaneld PM, Prasad N, Yin T, Figueroa DA, Musick WL, Cottreau JM, Hu M, Tam VH. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy. Antimicrob Agents Chemother 2014;58:2740-6.
• Quidley AM, Bland CM, Bookstaver PB, Kuper K. Perioperative management of bariatric surgery patients. Am J Health Syst Pharm 2014;71:1253-64.
• Rhodes NJ, MacVane SH, Kuti JL, Scheetz MH. Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes. Clin Infect Dis 2014;59:905-7.
• Rhodes NJ, Richardson CL, Heraty R, Liu J, Malczynski M, Qi C, Scheetz MH. Unacceptably high error rates in Vitek 2 testing of cefepime susceptibility in extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob Agents Chemother 2014;58:3757-61.
• Rose L, Bias TE, Mathias CB, Trooskin SB, Fong JJ. Sofosbuvir: a nucleotide NS5B inhibitor for the treatment of chronic hepatitis C infection. Ann Pharmacother 2014;48:1019-29.
• Rose L, Coulter MM, Chan S, Hossain J, Di Pentima MC. The quest for the best metric of antibiotic use and its correlation with the emergence of fluoroquinolone resistance in children. Pediatr Infect Dis J 2014;33:e158-61.
• Trivedi K, Kuper K. Hospital antimicrobial stewardship in the nonuniversity setting. Infect Dis Clin North Am 2014;28:281-9.
• Vargo C, Bauer K, Mangino J, Johnston J, Goff DA. Fidaxomicin: a case series of an antimicrobial stewardship program’s real world experience at an academic medical center. Pharmacotherapy 2014.
• Viswesh V, Green MR, Armstrong EP. Efficacy of an alternative dosing strategy of meropenem in the treatment of high-risk febrile neutropenia in adult subjects. Infect Dis Clin Pract 2014. [Epub ahead of print]

Other Notable Achievements:

• Sandy Estrada has been elected secretary/treasurer of the Society of Infectious Diseases Pharmacists (SIDP).
• Ivy Ge has been invited for an oral presentation, “Appropriate Antibiotic Therapy Is Associated with Reduced Risk of Community-Acquired Clostridium difficile Infection,” at the ID Week in Philadelphia on October 11, 2014.
• Emily Heil received Added Qualifications in Infectious Diseases (AQ-ID) certification.
• Paul Lata became a Board Certified Pharmacotherapy Specialist (BCPS).
• Kristi Ryzner became a Board Certified Pharmacotherapy Specialist (BCPS) with Added Qualifications in Infectious Diseases (AQ-ID) certification.
• Marisel Segarra-Newnham renewed Added Qualifications in Infectious Diseases (AQ-ID) certification.

Current Officers

• Chair (2013–2014) - Bob John, Pharm.D., BCPS
• Immediate Past Chair - Hanna Phan, Pharm.D., BCPS
• Chair-Elect - Joseph LaRochelle, Pharm.D.
• Secretary - Janie Robles, Pharm.D.

Collaboration Committee (Chair: Joseph LaRochelle)

The Collaboration Committee has been hard at work on a major group paper. The Board of ACCP reviewed a proposal from the group and provided constructive feedback. The team reworked the first draft to produce a new draft titled “The Value of the Pediatric Clinical Pharmacist.” A team of editors are currently editing this draft to produce the final document. After an external review, it will be submitted to ACCP for final review. The committee believes this document will be a useful tool for pharmacists, physicians, hospital administrators, and other health care professionals.

Education Committee (Chair: Christina Piro)

The committee has been busily planning for the upcoming 2014 ACCP Annual Meeting PRN focus session. Because of member feedback, this year’s session will feature “Clinical Controversies in Pediatric Critical Care.” Placing renewed discussion among the pediatric community on the management of pulmonary hypertension, the first hour will address optimizing medication dosing across the pediatric population. In addition, many institutions are seeing a rise in the number of designer drug–related admissions, with little standardization of management approach. The second hour of programming will focus on reviewing current data in order to select appropriate management strategies. The Education Committee is charged with developing session proposals for the Annual Meeting. These proposals will rely heavily on PRN input and suggestions for topics. If you have any suggestions for future meetings, please contact the committee.

Nominations Committee (Chair: Tracy Hagemann)

The Nominations Committee sought candidates for chair-elect this year because the PRN’s secretary/treasurer position is elected only every other year. In response to an e-mail call for nominations, two were received, but only one person submitted all the required materials before the deadline. Christina Cox, assistant professor at South Carolina College of Pharmacy, was slated for and elected to the office of chair-elect. Congratulations, Christina!

Student and Resident Committee (Chair: Chasity Shelton)

We are developing a survey to administer to 2013–2014 student/resident/fellow members to determine whether they obtained a residency/fellowship/job and whether it was in the field of pediatrics or another field. We hope to present these data at the Annual Meeting.

We are going to survey 2014–2015 members to determine additional needs/wants from the committee. We would like to assign mentor/mentee pairs before the Annual Meeting. A sign-up list will be sent in September to pair mentors/mentees and will inquire whether they are attending the Annual Meeting. We would like to pair up those who are attending to allow them to meet face-to-face at the meeting (if they are not already from the same institution/area). Right now, we see our primary committee role as providing mentorship/networking opportunities to student/resident/fellow members. Research Committee (Chair: Varsha Bhatt-Mehta)

This being the first year for the Research Committee, the committee held several meetings to define its charges and develop a charter, which is currently under review. The goal of the Pediatrics PRN PBRN is to work under the umbrella of this parent ACCP PBRN and perform practice-based, patient outcomes–oriented research using the talent within the PRN to further pediatric pharmacotherapy research and the goals of the ACCP PBRN by closely collaborating and supporting its activities. Recently, the committee submitted an anticoagulation study to the Project Intake Committee for the PBRN.

Travel Award Committee (Chair: Hanna Phan)

For 2014, two travel awards ($1000 each) were available to the Pediatrics PRN membership—(1) a Student Travel Award and (2) a Resident/Fellow Travel Award. Applicants for these awards are Pediatrics PRN student/resident/fellow members who are presenting (e.g., poster) at the 2014 ACCP Annual Meeting. Recipients of the award will be recognized at the annual PRN business meeting and will present their projects to those in attendance. Award recipients will also be recognized through announcement on the PRN e-mail list and the Spring PRN Report. The number of award applicants has increased over the years, which shows a greater awareness of students and residents/fellows about the Pediatrics PRN and its commitment to supporting future pediatric pharmacists. This award would not be possible without the efforts of its application reviewers and the support of the Pediatrics PRN membership. The committee would like to thank all reviewers through the years for their time and expertise and the Pediatrics PRN membership for supporting this award!

Promotions:

• Joseph M. LaRochelle, Pharm.D., was promoted to clinical associate professor of pediatrics.

Awards:

• Bob John: Presidential citation from PPAG
• Kalen Manasco: Spirit of PPAG Award
• Kimberly Novak, Pharm.D., BCPS: Central Ohio Cystic Fibrosis Foundation, Columbus’ Finest Award for Outstanding Young Professionals

Grants:

• 2014 ASHP New Investigator Grant. Phan H, Erstad BL, Billheimer D, Brown MA. Project: “Pharmacist Collaborative Practice in the Management of High-Risk Pediatric Asthma”

Publications:

• Sandra Benavides:
  • Editor of the “Pediatric Pharmacotherapy Self-Assessment,” to be published in October by ASHP. Citation: Benavides S, Phan H, Nahata MC, eds. Pediatric Pharmacotherapy Self-Assessment. Bethesda, MD: American Society of Health-System Pharmacists; anticipated release September 15, 2014.
  • Wrote or cowrote cases on nutrition, nephrotic syndrome, diabetic ketoacidosis, hypothyroidism in pediatric patients, and type 2 diabetes mellitus in pediatric patients
  • Cowrote the introductory chapter titled “Clinical Assessment of the Pediatric Patient”
• Nicholas Fusco:
  • Fusco NM, Parbuoni K, Morgan JA. Drug utilization, dosing, and costs after implementation of intravenous acetaminophen guidelines for pediatric patients. J Pediatr Pharmacol Ther 2014;19:35-41.
• Bob M. John:
  • Honey BL, John B, Farnen T, Mausner P. Probiotic use in children. The Rx Consultant 2013; 22: 1-11.
  • Kelly A, Kennedy AR, John BM, Little J, Lemanowicz J, Duane B. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients. Ann Pharmacother 2013;47:644-50.
  • Lloyd AE, Honey BL, John BM, Condren M. Treatment options and considerations for intestinal helminthic infections. J Pharm Technol 2014;30:130-9.
• Pete Johnson:
  • Cottrell M, Rathbun C, Webb R, Johnson PN, Lockhart S. Implications for hepatitis C treatment and disease progression in an HIV/HCV co-infected population. J Virol Antivir Res. Published online at doi: 10.4172/2324-8955.1000114.
  • Johnson PN, Benefield EC, Bui PN, Gausaman JN, Marlar RA, Gessouroun M. Fondaparinux monitoring: need for a local fondaparinux calibrated anti-factor Xa assay. J Pediatr Pharmacol Ther 2013;18:318-9.
  • Johnson PN, Benefield EC, Bui PN, Marlar RA, Gessouroun M. Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failure. J Pediatr Pharmacol Ther 2013;18:303-10.
  • Johnson PN, Miller JL, Hagemann TM, Castro C, Harrison D. External validation of the Medication Taper Complexity Score for methadone tapers in children with opioid abstinence syndrome. Ann Pharmacother 2014;48:187-95.
  • Lammers EM, Johnson PN, Ernst KD, Hagemann TM, Lawrence SM, Williams PK, Anderson MP, Miller JM. Association of continuous infusion fentanyl on neurodevelopmental outcomes in very low birth weight infants. Ann Pharmacother 2014;48:335-42.
  • Miller M, Burton MB, Johnson PN, Miller JL. Once-daily dosing versus extended interval dosing in neonates: the need for a change in terminology. Am J Health Syst Pharm. In press.
  • Miller MM, Johnson PN, Hagemann TM, Carter SM, Miller JL. Pseudo-hyperphosphatemia in pediatric patients prescribed liposomal amphotericin. Am J Health Syst Pharm. In press.
  • Miller JL, Schaefer J, Tam M, Harrison D, Johnson PN. Ethacrynic acid continuous infusions in pediatric patients. J Pediatr Pharmacol Ther 2014;19:50-6.
  • Miller JM, Thomas AN. Johnson PN. Continuous infusions of loop diuretics in critically ill children. Pharmacotherapy. In press.
• Joseph LaRochelle:
  • Johnson JL, Crawford LD, LaRochelle JM. A summer diabetes as an interprofessional service-learning experience for early experiential pharmacy students. Curr Pharm Teach Learn 2014;6:494-501.
• Kalen Manasco:
  • Rozette NA, Matragoon S, Sethi S, Goei S, Manasco KB, El-Remessy AB. Systemic effects of ophthalmic cyclopentolate on body weight in neonatal mice. Neonatology 2014;106:37-41.
• Hanna Phan:
  • Benavides S, Phan H, Nahata MC, eds. Pediatric Pharmacotherapy Self-Assessment. Bethesda, MD: American Society of Health-System Pharmacists. Pending release, fall 2014.
  • Daines CL, Drake G, McGuire M, Parker M, Settle P, Werchan B, Phan H. Redesigning inpatient cystic fibrosis care. Pediatr Pulmonol 2013;48(suppl 36):392.
  • Daines CL, Phan H, McGuire M, Parker M, Settle P, Werchan B, Drake G. Impact of a dedicated respiratory care team on inpatient pulmonary outcomes. Pediatr Pulmonol 2013;48(suppl 36):392.
  • Phan H, Edwards CJ. Diabetic ketoacidosis. In: Katz MD, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy: Principles and Practice Casebook, 3rd ed. New York: McGraw-Hill, 2014:197-200.
  • Phan H, Even NM. Cystic fibrosis. In: Katz MD, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy: Principles and Practice Casebook, 3rd ed. New York: McGraw-Hill, 2014:67-70.
  • Phan H, Nelson LC. Pediatric immunizations. In: Katz MD, Matthias KR, Chisholm-Burns MA, eds. Pharmacotherapy: Principles and Practice Casebook. New York: McGraw-Hill, 2014:391-4.
  • Wheatley CM, Baker SE, Daines CL, Phan H, Morgan WJ, Snyder EM. Influence of the Vibralung device on pulmonary function and sputum expectoration in patients with cystic fibrosis. Pediatr Pulmonol 2013;48(suppl 36):357.
• Katherine Smith:
  • Smith KP, Madison CM, Milne NM. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults. Pharmacotherapy 2014. In press.
  • Wang Y, Smith KP. Alternative antiviral agents for neonatal herpes simplex virus (HSV) encephalitis and disseminated infection. J Pediatr Pharmacol Ther 2014;19:72-82.

New ACCP Fellows:

• Sandra Benavides, Pharm.D., Austin, Texas (will be inducted at Annual Meeting)

Other Notable Achievements:

• Sara Benavides
  • Sandra Benavides, Pharm.D., Nashville, Tennessee: Inducted as FPPAG (fellow in PPAG)
• Nicholas Fusco
  • 2014 graduate of ACCP Research and Scholarship Certificate Program
• Hanna Phan
  • Elected to PPAG board as director-at-large for 2014–2017

GRANTS:

Timothy Bensman received an F31 fellowship from the NIH titled “Theta Defensins for Targeting the Metalloproteinase System in CF Airway Disease.”

PUBLICATIONS:

• Caudle KE, Klein TE, Hoffman JM, Muller DJ, Whirl-Carrillo M, Gong L, McDonagh EM, Sangkuhl K, Thorn CF, Schwab M, Agundez JA, Freimuth RR, Huser V, Lee MT, Iwuchukwu OF, Crews KR, Scott SA, Wadelius M, Swen JJ, Tyndale RF, Stein CM, Roden D, Relling MV, Williams MS, Johnson SG. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab 2014;15:209-17.
• Clancy JP, Johnson SG, Yee SW, McDonagh EM, Caudle KE, Klein TE, Cannavo M, Giacomini KM. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype. Clin Pharmacol Ther 2014;95:592-7.
• Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, Caudle KE, Haidar CE, Shen DD, Callaghan JT, Sadhasivam S, Prows CA, Kharasch ED, Skaar TC. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther 2014;95:376-82.
• Dressler LG, Deal AM, Patel JN, Markey J, Van Riper M, McLeod HL. Cancer Pharmacogenomics, adoption by oncologists and patient benefit. Pers Med 2014;11:143-53.
• Gillis N, Patel JN, Innocenti F. Clinical implementation of germline cancer pharmacogenetic variants during the next-generation sequencing era. Clin Pharmacol Ther 2014;95:269-80.
• Muir AJ, Gong L, Johnson SG, Lee MT, Williams MS, Klein TE, Caudle KE, Nelson DR. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimens. Clin Pharmacol Ther 2014;95:141-6.
• Patel JN, O’Neil BH, Deal AM, et al. A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil (5-FU) dosing for personalized colorectal cancer therapy. Oncologist 2014. Accepted for publication.
• Ramsey LB, Johnson SG, Caudle KE, Haidar CE, Voora D, Wilke RA, Maxwell WD, McLeod HL, Krauss RM, Roden DM, Feng Q, Cooper-DeHoff RM, Gong L, Klein TE, Wadelius M, Niemi M. The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. Clin Pharmacol Ther 2014 Jun 11. [Epub ahead of print]
• Relling MV, McDonagh EM, Chang T, Caudle KE, McLeod HL, Haidar CE, Klein T, Luzzatto L. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype. Clin Pharmacol Ther 2014 May 2. [Epub ahead of print]
• Whaley SG, Caudle KE, Vermitsky JP, Chadwick SG, Toner G, Barker KS, Gygax SE, Rogers PD. UPC2A is required for high-level azole antifungal resistance in Candida glabrata. Antimicrob Agents Chemother 2014 May 27. [Epub ahead of print]

Book Chapters

• Carr RR, Decarie D, Ensom MHH. Stability of epinephrine in standard concentrations. Can J Hosp Pharm 2014;67:197-202.
• Contreiras C, Legal M, Lau TTY, Thalakada R, Shalansky S, Ensom MHH. Identification of risk factors for nephrotoxicity in patients receiving extended-duration high-trough vancomycin therapy. Can J Hosp Pharm 2014;67:126-32.
• Kendrick J, Ensom MHH, Steer A, White C, Kwan E, Carr RR. Standard-dose versus high-dose acyclovir in children treated empirically for encephalitis: a retrospective cohort study of its use and safety. Paediatr Drugs 2014;16:229-34.
• Kiang TKL, Häfeli UO, Ensom MHH. A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring. Clin Pharmacokinet 2014 Jun 28. [Epub ahead of print]
• Kiang TKL, Wilby KJ, Ensom MHH. Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals. Clin Pharmacokinet 2014;53:141-53.
• Ma C, Decarie D, Ensom MHH. Stability of clonidine suspension in oral plastic syringes. Am J Health Syst Pharm 2014;71:657-61.
• Ng K, Mabasa VH, Chow I, Ensom MHH. Systematic review of efficacy, pharmacokinetics and administration of intraventricular vancomycin in adults. Neurocrit Care 2014;20:158-71.
• Patel JN, McLeod HL. Pharmacogenomics and cancer therapy: somatic and germ-line polymorphisms. In: Figg WD, McLeod HL, eds. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, 2nd ed. Totowa, NJ: Humana Press, 2014:255-72.

AWARDS

Mary H.H. Ensom received the Class of 2014 Master Teacher Award, University of British Columbia Faculty of Pharmaceutical Sciences (May 2014).

Kassandra Bartelme, Pharm.D., BCACP

Publication

• Original Research – Bartelme K, Bzowyckyj A, Frueh J, Speedie M, Jacobson G, Sorensen TD. Experience and outcomes of a pharmaceutical care leadership residency program. Innov Pharm 2014;5:Article TBA. www.pharmacy.umn.edu/innovations/prod/groups/cop/@pub/@cop/@innov/documents/article/cop_article_486296.pdf

Gerald Briggs, BPharm, FCCP

Publications

• 10th edition of Drugs in Pregnancy and Lactation occurred on August 8, 2014
• Added two new coauthors and will be working on the 11th edition with Roger Freeman and me: Craig Towers, M.D., a maternal-fetal medicine specialist in Tennessee; and Alicia Forinash, Pharm.D., FCCP, BCPS, BCACP, at the St. Louis College of Pharmacy

Other

• Sponsoring a pharmacist resident with an emphasis on obstetrics at Sacred Heart Hospital, Spokane, Washington. The resident will assume a clinical pharmacist position at the hospital, working with maternal-fetal medicine physicians, when she completes her residency. Her emphasis will be on showing cost-effectiveness for her practice.

Leadership

• Continued as the co-chair, together with Janine Polifka, Ph.D., of the Research Committee, Organization of Teratology Information Specialist (OTIS), a position that I have held for 15 years; the committee oversees national and international research on drug exposure in human pregnancies
• Retired from Long Beach Memorial Medical Center, Long Beach, California, on June 30, 2014, after 42½ years

Alicia Forinash, Pharm.D., FCCP, BCPS, BCACP

Publications

• Cowrote a PRN opinion paper – “Roles of the Pharmacist in the Use of Safe and Effective Long-Acting Reversible Contraception” by Sally Rafie, Jennifer McIntosh, Kayce Shealy, Laura Borgelt, Alicia Forinash, Sarah Shrader, Erin Koepf, Katie McClendon, Brooke Griffin, Cheryl Horlen, Lamis Karaoui, Emily Rowe, Nicole Lodise, and Patricia Wigle published in Pharmacotherapy (July 2014)
• Added as a coauthor to the 11th edition of Drugs in Pregnancy and Lactation by Gerald Briggs, BPharm, FCCP

Brooke L. Griffin, Pharm.D., BCACP

Publications

• PRN opinion paper – “Roles of the Pharmacist in the Use of Safe and Effective Long-Acting Reversible Contraception” by Sally Rafie, Jennifer McIntosh, Kayce Shealy, Laura Borgelt, Alicia Forinash, Sarah Shrader, Erin Koepf, Katie McClendon, Brooke Griffin, Cheryl Horlen, Lamis Karaoui, Emily Rowe, Nicole Lodise, and Patricia Wigle. Published in Pharmacotherapy (July 2014)

Elected Women’s Health PRN officer 2014–2015

Chair-Elect

Erin R. Koepf, Pharm.D., BCACP

Publication

• PRN opinion paper – “Roles of the Pharmacist in the Use of Safe and Effective Long-Acting Reversible Contraception” by Sally Rafie, Jennifer McIntosh, Kayce Shealy, Laura Borgelt, Alicia Forinash, Sarah Shrader, Erin Koepf, Katie McClendon, Brooke Griffin, Cheryl Horlen, Lamis Karaoui, Emily Rowe, Nicole Lodise, and Patricia Wigle. Published in Pharmacotherapy (July 2014)

Elected Women’s Health PRN officer 2014–2015

Public Policy Liaison

Christina M. Madison, Pharm.D., BCACP, AAHIVP

Award

• Silver Syringe Award (accepted August 2014) given by the Southern Nevada Immunization and Health Coalition (SNIHC)
• Outstanding Pharmacy Immunization Program – for initiation and implementation of routine immunization service at the Southern Nevada Health District (SNHD) Sexual Health Clinic

Publication

• Article title: “Gonadal Suppressive and Cross-Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults” by Katherine P. Smith, Christina M. Madison, and Nikki Milne

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Accepted for publication and in galley proofs, to be published fall 2014.

Nikki Milne, Pharm.D., BCPS

Publication

• Article title: “Gonadal Suppressive and Cross-Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults” by Katherine P. Smith, Christina M. Madison, and Nikki Milne

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Manuscript accepted for publication and in galley proofs, to be published fall 2014.

Sally Rafie, Pharm.D., BCPS

Women’s Health PRN officer 2014–2015

Chair

Publications

• First author of PRN opinion paper – “Roles of the Pharmacist in the Use of Safe and Effective Long-Acting Reversible Contraception” by Sally Rafie, Jennifer McIntosh, Kayce Shealy, Laura Borgelt, Alicia Forinash, Sarah Shrader, Erin Koepf, Katie McClendon, Brooke Griffin, Cheryl Horlen, Lamis Karaoui, Emily Rowe, Nicole Lodise, and Patricia Wigle. Published in Pharmacotherapy (July 2014)
• Letter to the Editor on “What Is the Restriction on Over-the-counter Emergency Contraception Access Today?” by Rebecca Stone, Nicole Lodise, Anna Morin, and Sally Rafie published in J Adolesc Health in July 2014.

Katherine P. Smith, Pharm.D., BCPS

Publication

• First author article title: “Gonadal Suppressive and Cross-Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults” by Katherine P. Smith, Christina M. Madison, and Nikki Milne Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Manuscript accepted for publication and in galley proofs, to be published fall 2014.

Rebecca H. Stone, Pharm.D., BCPS, BCACP

Publication

• First author – Letter to the Editor on “What Is the Restriction on Over-the-counter Emergency Contraception Access Today?” by Rebecca Stone, Nicole Lodise, Anna Morin, and Sally Rafie published in J Adolesc Health in July 2014

Elected Women’s Health PRN officer 2014–2015

Secretary/Treasurer

New ACCP Fellows 2014

• Sarah P. Shrader, Pharm.D., BCPS; Prairie Village, KS
• Mary E. Temple Cooper, Pharm.D., M.S., BCPS; Chagrin Falls, OH